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ABSTRACT

THE UNAVOIDABLE THREAT OF AGGREGATION:
IMPLICATIONS ON FOLDING AND FUNCTION OF A β-RICH PROTEIN
MAY 2013
MYLENE CASTELL FERROLINO
B.S. UNIVERSITY OF THE PHILIPPINES
M.S., UNIVERSITY OF THE PHILIPPINES
PH.D., UNIVERSITY OF THE MASSACHUSETTS
Directed by: Professor Lila M. Gierasch

Protein

aggregation

has

been

implicated

in

several

catastrophic

diseases

(neurodegeneration, diabetes, ALS) and its complexity has also become a major
obstacle in large-scale production of protein-based therapeutics. Despite the generic
behavior of proteins to aggregate, only a few globular proteins have known aggregation
mechanisms. At present, there have been no clear connections between protein folding,
function and aggregation. We have tackled the challenge of understanding the links
between a protein’s natural tendency to fold and function with its propensity to misfold
and aggregate. Using a predominantly β-sheet protein whose in vitro folding has been
explored in detail: cellular retinoic acid-binding protein I (CRABP 1), as a model, we
investigated sequence determinants for folding and aggregation. In addition, we
characterized the aggregation-prone intermediate under native conditions. Our studies
revealed similar contiguous aggregation cores in in vitro and in vivo aggregates of
CRABP 1 validating the importance of sequence information under extremely different
conditions. Hydrophobic stretches that comprise the interface in aggregates include

vii

residues surrounding the ligand binding portal and residues at the C-terminal strands of
CRABP 1. Folding studies reveal that docking of the N and C terminals happen in the
early stages of barrel closure of CRABP 1 emphasizing the role of folding in preventing
exposure of risky aggregation-prone sequences. We further examined the intermediate
that initiates aggregation under native conditions. We found that inherent structural
fluctuations in the native protein, relevant to ligand binding of CRABP 1, expose
aggregation-prone sequences. Binding of the ligand, retinoic acid decreases the
aggregation of CRABP 1 illustrating the contribution of functional interactions in avoiding
aggregation. Our study implies that because of the evolutionary requirement for proteins
to fold and function, aggregation becomes an unavoidable risk.
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CHAPTER 1

INTRODUCTION

1.1.

Competitive Interactions in Protein Folding and Aggregation
Proteins have encoded in their amino acid sequence highly feasible interactions

that direct folding into their lowest energy three-dimensional functional state. The
intrinsic property of proteins to achieve a shape that is thermodynamically stable has
been originally demonstrated in Christian B. Anfinsen’s experiment where the unfolded
protein spontaneously re-acquires its three-dimensional structure upon removal of
denaturant (Anfinsen, 1973). At infinite dilution, intramolecular contacts leading to
natively folded proteins are highly favored. Nonetheless, above infinite dilution, folding
competes with stable intermolecular contacts leading to oligomers and aggregates.

Proteins are able to fold efficiently in a biologically suitable timescale despite the
enormous conformational space that a protein can sample under a given condition
(Bartlett & Radford, 2009). The paradox between the time required for random unbiased
conformational search to achieve the native state and the folding time of proteins can be
explained by the existence of well-defined pathways (Karplus, 1997, Bartlett & Radford,
2009). Dill and Chan have described the protein folding framework using folding not only
as two dimensional pathways but as multi-dimensional funnels and free energy
landscapes (Figure 1) (Dill & Chan, 1997). Folding free energy landscapes describe the
narrowing of conformational space of the unfolded state in a downward direction to the
lowest free energy native state (Dill & Chan, 1997). Robust folders containing naturally
selected amino acid sequences are viewed as smooth funnels (Dill & Chan, 1997). On
the other hand, proteins with more complex folding pathways are represented with
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rugged energy landscapes containing kinetically trapped intermediates. The hierarchy of
local minima represents bottleneck conformations of either on-pathway or off-pathway
intermediates (Dill & Chan, 1997, Milanesi, et al., 2012). The ability to surmount the
energy barriers associated with kinetic traps dictates the rate of folding of a protein.

Energy landscapes are not only used to describe protein folding but protein
motions as well. Although the native state is illustrated as the single lowest energy
minima in a folding landscape, a closer examination reveals multiple low-barrier energy
wells representing populations in the native state ensemble (Frauenfelder, et al., 1991,
Frauenfelder, et al., 2007). These conformations are thermodynamically distinct but
structurally similar (Chiti & Dobson, 2009). Structural fluctuations have been associated
with biological functions of proteins and thus are very important aspects in the study of
proteins. “Breathing” motions of proteins have recently been linked to aggregation. In
Chapter 3 of this thesis, we will describe protein dynamics in more detail including its
coupled contributions to function and aggregation.

2

Figure 1.1. Example of free energy landscape for folding of proteins. Folding of
proteins can be illustrated from physical point of view using energy funnels. Multi-state
folders are represented with rugged energy landscapes containing several energy
minima portraying kinetically trapped intermediates. Energy barriers govern the rate of
protein
folding.
This
figure
is
re-printed
from
Ken
Dill’s
website:
http://dillgroup.stonybrook.edu/energy-landscapes.
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The primary sequence of a protein defines its energy landscape and its path to
the native state. However, the amino acid sequence also encodes the protein’s ability to
form intermolecular contacts required for functional oligomerization or dysfunctional
aggregation. The burial of hydrophobic segments in a native protein and in surfaces
stabilizing protein aggregates suggests common physico-chemical constraints governing
both folding and aggregation (Linding, et al., 2004, Routledge, et al., 2009). Hence, an
integrated energy landscape for folding and aggregation is necessary to predict the fate
of a polypeptide chain. Under finite dilutions, intramolecular associations leading to
stably folded states compete with intermolecular contacts that lead to functional or nonfunctional oligomers or highly stable insoluble aggregates. This can be envisioned as
overlapping energy landscapes for folding and aggregation (Figure 1. 2) (Clark, 2004,
Hartl & Hayer-Hartl, 2009). Energy wells in the folding landscape represent
intermediates where destabilizing conditions can overcome an energy barrier and
access the aggregation landscape (Clark, 2004, Hartl & Hayer-Hartl, 2009). As a
consequence the equilibrium is pulled into the extremely stable aggregated state.
Energy landscapes suggest correlation between thermodynamic stabilities and
aggregation propensities and their dependence on the kinetic barriers that separate the
states (Agostini, et al., 2012). Thus, changes in the folding energy landscape from
destabilizing mutations or alterations in solution conditions (pH, temperature, ionic
strength, pressure) may increase the aggregation propensity (Linding, et al., 2004).
There is however growing evidence, suggesting aggregation of proteins may occur
under native conditions which do not require significant destabilization of proteins (Chiti
& Dobson, 2009). Structural fluctuations result in an ensemble of native-like species
described in multiple low energy barriers. Low populations of slightly higher energy
states can derail folding and lead to aggregation (Neudecker, et al., 2012).

5

Figure 1.2. Schematic integrated folding and aggregation energy landscape of
proteins. Similar physico-chemical properties that govern intramolecular and
intermolecular contacts result in an overlap (purple) in energy landscapes for folding
(blue) and aggregation (red). Wells on energy landscapes represent kinetically trapped
intermediates - on-pathway (Ion), off-pathway (Ioff) or near native (N*) intermediates, that
can lead either to natively folded proteins or aggregates.

6
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1.2. Characteristics of Protein Aggregates
Aggregation is a concentration-dependent self-assembly of misfolded proteins
yielding either highly ordered or amorphous insoluble deposits (Sugiyama, et al., 2010).
Protein aggregation typically results in loss-of-function or a gain-of-function resulting to
cellular toxicity. For decades, huge interest in understanding protein aggregation has
been attributed to its direct implications in serious diseases. Cellular protein aggregates
are highly abundant in several neurodegenerative diseases (e.g. Alzheimer’s diseases,
Parkinson’s disease and Huntington’s disease), prion-related diseases (CreutzfeldtJacob disease and kuru), type 2 diabetes, hemodialysis related diseases, inherited
cataracts and amyloidosis (Chiti & Dobson, 2006). From a cellular point of view, toxicity
derived from aggregation is linked to obstruction of the protein quality control
machineries, which include molecular chaperones and proteases, depletion of essential
proteins and build-up of toxic polypeptides (Sanchez de Groot, et al., 2012). However,
aggregation is not only associated with pathological conditions but can be beneficial as
well. Under highly regulated conditions several organisms are able to exploit aggregation
for function. Functional aggregates are exemplified in the case of an E. coli protein,
curlin, found to be essential in colonizing inert surfaces, forming biofilms and mediating
host protein binding (Chapman, et al., 2002). Functional aggregates are also found in
higher organisms such as aggregates formed by the protein Pmel17 involved in melanin
production (Berson, et al., 2003). Peptide and protein hormones are also stored in cells
in the form of protein aggregates (Maji, et al., 2009). In addition, aggregates also
function as inheritable non-chromosomal genetic elements which is exhibited by prion
protein aggregates (Wickner, et al., 2013).

8

The most characterized forms of protein aggregates are the highly structured
amyloid fibrils. Amyloids consist of repeated β-strands that run perpendicular to the fiber
axis assembling into stacked cross-β sheets (Tycko, 2006). These very stable amyloid
“cores” are highly solvent protected and protease resistant (Hoshino, et al., 2002, Frare,
et al., 2006). Interestingly these stable aggregation cores are only comprised of very
short (5-15 residues) hydrophobic and low charged segments (Chiti, et al., 2003,
Fernandez-Escamilla, et al., 2004, Beerten, et al., 2013). Aggregation cores are typically
made up of amino acids with aliphatic side chains (valine, leucine and isoleucine) and
aromatic side chains (Sanchez de Groot, et al., 2012). Amyloid fibrils contain rope-like
structures of twisted protofilaments (Sunde, et al., 1997, Serpell, et al., 2000). The
regular cross-β cores of amyloids specifically bind to congo red and thioflavin T (LeVine,
1999, Westermark, et al., 1999, Biancalana & Koide, 2010). Amyloids are formed via an
initial nucleation lag phase involving the population of a rare misfolded intermediate,
followed by a rapid exponential growth phase, where monomers or oligomers associate
with the nucleus (Chiti & Dobson, 2006).

In contrast to amyloids, the mechanism of amorphous aggregation is less
explored. Amorphous aggregates have been of significant interest in the microbiology
and biotechnology fields as these are commonly found in bacterial inclusion bodies
during over-expression of heterologous proteins (de Groot, et al., 2008). Despite the
non-fibrillar, amorphous appearance, several studies revealed presence of ordered
amyloid-like core structures in bacterial inclusion body deposits (Carrio, et al., 2005,
Wang, et al., 2008, de Groot, et al., 2009). Interestingly, globular proteins in these
bacterial aggregates are still able to retain their functional native-like conformations
(Garcia-Fruitos, et al., 2005, Ventura & Villaverde, 2006). Recently, amorphous
aggregates have also been implicated in diseases such as in aggregated lenticular αB9

crystallins in cataracts (Sugiyama, et al., 2010). Furthermore, prefibrillar aggregates that
are currently argued to cause toxicity in amyloid diseases appeared amorphous
(Dobson, 2003, Meredith, 2005). The kinetics of amorphous aggregation is proposed to
be similar to a glass transition (Yoshimura, et al., 2012). Glass-like properties in
amorphous aggregates observed swap domains and restructure into stable species
during intense salting-out (Yoshimura, et al., 2012). This suggested the possible role of
amorphous aggregation as a preliminary step towards amyloid formation (Yoshimura, et
al., 2012). It has been shown that under defined conditions proteins either form amyloids
and amorphous aggregates or both (Morshedi, et al., 2010). Although the morphologies
of aggregates may vary within the same or across different proteins, stretches engaging
in stabilization of aggregates have similar properties. Experimentally determined
properties of aggregation prone segments can be used to train algorithms for forecasting
aggregation tendencies. Thus, sequence-based predictions for aggregation have been
useful tools in screening aggregation-prone segments and evaluating aggregation
propensities for a large number of proteins.

1.3. Prediction of Aggregation-Prone Sequences Proteins
A protein’s thermodynamic stability, structural class and amino acid sequence of
proteins all govern aggregation propensities. (Conchillo-Sole, et al., 2007, Niwa, et al.,
2009, Tartaglia & Vendruscolo, 2010, Agostini, et al., 2012). However, there is not a
huge amount of information available on stabilities of proteins. We also do not know
much about the aggregation propensities of different structural classes. Hence,
correlating aggregation with amino acid sequences is the only convenient way to provide
initial clues on the aggregation tendencies of proteins. Furthermore, we can apply these
to find relationships for natural selection and to optimize conditions in controlling self10

assembly. Several aggregation prediction algorithms have been developed over the
years that exploit the plethora of studies on experimentally identified residues of proteins
participating in aggregation. These algorithms aimed to distinguish short specific amino
acid stretches engaging in aggregates and predict overall aggregation propensities of
proteins. At present these have been used to forecast aggregation propensities for an
enormous number of proteins both in bacterial and eukaryotic proteomes (de Groot &
Ventura, 2010, Tartaglia & Vendruscolo, 2010, Grana-Montes, et al., 2012). Here we will
briefly describe experimentally validated aggregation predictors namely, AGGRESCAN,
PASTA, TANGO and Zyggregator that we used in the study.

AGGRESCAN predicts “aggregation hotspots” based on hydrophobicity, β-sheet
propensity and charge of amino acid side chains (de Groot, et al., 2006, Conchillo-Sole,
et al., 2007). Aggregation propensities are calculated from the analysis of single residue
substitutions in an aggregation-prone sequence (the hydrophobic cluster of Aβ) in the
context of the full-length polypeptide (GFP fusion acting as an aggregation reporter) and
not as an isolated short peptide (Conchillo-Sole, et al., 2007). The calculations are
based on previously determined aggregation-propensity values per amino acid (a3v)
averaged over a sliding window of a given length (a4v) (Conchillo-Sole, et al., 2007). A
region in the polypeptide sequence is considered an aggregation "hot spot" (HS) if there
are five or more contiguous residues (none is a proline) with an a4v larger than the HST
("hot spot" threshold defined as the average of the a3v of the 20 amino acids weighted
by their frequencies in the SwissProt)(Conchillo-Sole, et al., 2007). AGGRESCAN has
been used in analyzing the aggregation propensities of protein kinase sequences in
human and other organisms to identify evolutionary pressures in this family of proteins
(Grana-Montes, et al., 2012). This method has also been exploited to find associations
between aggregation propensity with length, conformation, location, function, and
11

abundance in cells (de Groot & Ventura, 2010). AGGRESCAN has been found to be
consistent with other aggregation predictors (de Groot & Ventura, 2010).

TANGO predicts β-aggregation in peptides and proteins based on a phase-space
covering major conformational states, namely the folded state, β-sheet, β-turn, α-helix
and β-aggregate (Fernandez-Escamilla, et al., 2004). Segments of a peptide can
populate each of these states following the Boltzmann distribution. Prediction of
aggregation segments by TANGO is simply calculating the partition function of the
phase-space (Fernandez-Escamilla, et al., 2004). TANGO has been previously used in
studying structural properties and mutational effects linked to aggregation (Linding, et
al., 2004). TANGO has also been used analyze several proteomes to find evolutionary
pressures that minimize aggregation (Rousseau, et al., 2006, Chen & Dokholyan, 2008).

PASTA calculates aggregation propensities based on similar parameters such as
β-propensity, hydrophobicity and charge of amino acid side chains. However PASTA can
also predicts the registry of the intermolecular hydrogen bonds formed between amyloid
sequence stretches (Trovato, et al., 2006). This is useful in envisioning the orientation of
β-strands in the aggregation cores with respect to each other.

Zyggregator, similar to all other aggregation prediction algorithms, takes into
account the hydrophobicity and secondary structure propensities of the amino acid side
chains to predict differential aggregation behaviors between polypeptides (Tartaglia &
Vendruscolo, 2008). In addition to this, Zyggregator also considers the intrinsic
aggregation propensity and the stability of a polypeptide to have a significant tendency
to form intermolecular interactions (Tartaglia & Vendruscolo, 2008). Aggregation
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propensities are reported as Zagg. Zyggregator has been employed to identify key
regions in proteins that affect aggregation rates (Routledge, et al., 2009). Also, it has
also been used to predict relationships of aggregation propensity with evolutionary
constraints at a proteome level (Tartaglia & Vendruscolo, 2010).

1.4. Aggregation Mechanisms of Globular Proteins
Despite the generality of aggregation in proteins and the abundance of
aggregation-prone proteins in vivo, only a handful of globular proteins have welldescribed aggregation mechanisms. Originally, it was recognized that aggregation
requires population of alternative protein conformations characterized by partially or
globally unfolded intermediates that transitions the native state over a high-energy
barrier of unfolding (Kelly, 1996, Chiti & Dobson, 2009). At conditions that favor
aggregation such as low pH, high temperature, high pressure, presence of co-solvents
or destabilizing mutations, the free energy of native state is increased relative to the
unfolded and intermediate states hence increasing the populations of these states (Chiti
& Dobson, 2009). When there is none or very minimal change in the free energy of the
transition state, then the native state will have increased kinetic accessibility to the
unfolded and intermediate states (Chiti & Dobson, 2009). Thus, population of these high
energy misfolded species promotes aggregation (Chiti & Dobson, 2009). Several
proteins have demonstrated tendencies to aggregate from a disordered state for obvious
reasons that aggregation-prone segments are exposed when unfolded. These have
added interest in the study of intrinsically disordered proteins (IDPs) in aggregation.

Some

examples

of

proteins

with

partially

unfolded

aggregation-prone

intermediates identified include β2-microglobulin (β2m), lysozyme, transthyretin and
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copper-zinc superoxide dismutase I (SOD I). β2-microglobulin, a 99 residue β-sandwich
protein deposited in the joints of patients suffering from dialysis related amyloidosis was
shown to aggregate in an acidic solvent (Platt & Radford, 2009). A 10-residue aromatic
rich amino acid stretch which controls the rate of aggregation of β2m is found to be
exposed in the a partially unfolded intermediate at low pH (Platt & Radford, 2009).
Human wild-type lysozyme at pH 5 and its mutants form molten globule-like
intermediates during aggregation (Booth, et al., 1997). In case of transthyretin,
aggregation accedes via a partially denatured monomer at conditions that mimic the pH
of the lysosome (Colon & Kelly, 1992). Several mutations in copper-zinc SOD I that lead
to amyotrophic lateral sclerosis significantly destabilize the β-barrel and dimerization
interfaces leading to aggregation (Perry, et al., 2010).

As mentioned earlier, there is a growing number of proteins demonstrating
aggregation without largely changing their conformation and surpassing high energy
barriers (Kelly, 1996, Kelly, 1998, Jahn, et al., 2006, Chiti & Dobson, 2009, Neudecker,
et al., 2012). Conformations of aggregation-prone states can be thermodynamically
distinct but almost structurally identical to the native state. These native-like or N* states
are accessed from the native state through thermal fluctuations (Chiti & Dobson, 2009).
N* states are at higher energy than the native proteins, but are only separated by a
relatively low energy barrier (Chiti & Dobson, 2009). Interestingly, globular proteins
under extremely different conditions (destabilizing or native conditions) contain the same
driving hydrophobic sequences to produce similar types of aggregates (Calamai, et al.,
2005). This is consistent with proteins possessing rugged aggregation energy
landscapes consisting of structurally diverse precursors.
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The proteins mentioned earlier alternatively aggregate at near physiological
conditions. A rarely populated native-like intermediate of β2-microglobulin containing a
non-native trans-proline isomer is found to favor aggregation (Eakin, et al., 2006, Jahn,
et al., 2006). Edge strands of β2m that normally protect β-sandwich proteins from selfassociation are perturbed in the aggregation precursor (Jahn, et al., 2006). Inherent
fluctuations associated with the native state also lead to aggregation of the mutant
lysozyme proteins (Chiti & Dobson, 2009). The aggregation-prone intermediate is a
partially unfolded state formed through a locally cooperative process and a conformation
thermodynamically distinct from the native state, but still on the native side of the free
energy barrier for unfolding (Chiti & Dobson, 2009). In the case of copper-zinc SOD I, a
metal and non-metal bound mutant S134N populates a near native intermediate that
permits transient soluble oligomers through an unfolded loop VII or electrostatic loop
leading to aggregation (Banci, et al., 2005). Transthyretin aggregates under native
conditions when the monomer undergoes local unfolding of peripheral strands yielding
exposed aggregation-prone β-strands (Olofsson, et al., 2004). Proteins like insulin and
acylphosphatase (AcP) from Sulfolobus solfataricus form native-like α-helical oligomeric
precursors that later undergo global structural reorganization to form amyloids
(Bouchard, et al., 2000, Chiti & Dobson, 2009). The growing evidence suggesting that
proteins apparently access aggregation-prone conformations that are near-native
indicates that the folded state remains at risk of aggregation.

1.5.

Protein Folding and Aggregation in the Cell
It is imperative to note that events observed in vitro do not fully recapitulate

folding and aggregation in the complex environment of the cell. Thus, what we learn in
vitro from a few model proteins is only seeing the tip of the iceberg. In vivo conditions
pose several challenges in predicting the fate of a protein. In the cell, newly synthesized
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polypeptides vectorially emerge from the ribosome permitting the N-terminal segments
of the protein to encounter an extremely complex and crowded environment during
folding that can exacerbate aggregation (Ellis & Minton, 2006, Gershenson & Gierasch,
2011, Zhang & Ignatova, 2011). In addition, the protein load in cells that needs to fold is
relatively large. It is estimated that 10-20% of residues in proteomes from prokaryotic
and eukaryotic organisms are aggregation-prone (Rousseau, et al., 2006). Although
macromolecular crowding is biased towards more compact states like the native fold, it
also

favors

specific

and

nonspecific

intermolecular

associations

(Gierasch

&

Gershenson, 2009). Inside the cell protein mobilities are also hindered, increasing the
chances for productive and non-productive encounters. In addition, macromolecular
crowding affects the viscosity of the protein environment thus affecting their folding rates
and mechanism (Gershenson & Gierasch, 2011). Increased risk of aggregation caused
by macromolecular crowding in the cell emphasizes the critical role of folding assistants
or molecular chaperones and efficient degradation machineries (Ellis & Minton, 2006,
Gershenson & Gierasch, 2011, Vendruscolo, 2012). This evolutionarily conserved
network of chaperones and proteases provides immediate cellular counter measures to
environmental stress in order to maintain protein homeostasis also known as
“proteostasis” (Hartl, et al., 2011, Powers & Balch, 2013). However, their roles in
assisting de novo folding and refolding have also been recognized under non-stressed
conditions (Richter, et al., 2010). In fact, there are a remarkable number of proteins
highly dependent on chaperones (Kerner, et al., 2005, Niwa, et al., 2009, Fujiwara, et al.,
2010, Calloni, et al., 2012). Molecular chaperones remodel the energy landscape of
proteins to favor productive folding over aggregation (Hartl, et al., 2011). There are five
major classes of molecular chaperones, which include: Hsp100s, Hsp90s, Hsp70s,
Hsp60s (chaperonins), and small heat shock proteins. These proteins either recognize
unfolded proteins to assist folding, bind native proteins to facilitate functions or disrupt
16

insoluble aggregates (Richter, et al., 2010). Molecular chaperones either enclose
unfolded proteins in a chamber to actively or passively assist folding as in the case of
Hsp60 or protect hydrophobic stretches from exposure as in the case of Hsp 70 (Zhu, et
al., 1996, Hartl, et al., 2011, Clare, et al., 2012). Hsp 90 assists in the late stage 
! ""!! !! ! 
 

    ##   ! $ " ! !  !" 

!!!  $  !$ ! ! !!
" !   !  !     Molecular chaperones work
simultaneously in an intricate network with proteases that degrade misfolded adds to the
increasing complexity of competing interactions with the polypeptide chain (Powers, et
al., 2012). Thus, it remains an enormous challenge to understand protein folding in the
cell.

1.6.

Statement of Dissertation
Despite the vast amount of information that is available, there is a lack of a

holistic view of the entwined folding and aggregation energy landscapes. Fundamental
questions continue to confound us: What are the sequence features of a polypeptide that
link folding and aggregation? Are mechanisms of aggregation observed in vitro
maintained in vivo? In addition, there has been very scarce evidence linking aggregation
propensity and evolutionary requirement to function. Hence we also ask: What can be
learned from our model protein CRABP 1 which has utilized several mechanisms to
avoid aggregation? How do inherent protein motions associated with function endanger
proteins towards aggregation? How do functional interactions offset aggregation
propensity? What are the cellular mechanisms that modulate aggregation without
compromising functions?
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In Chapter 2 of this thesis, sequence determinants that drive in vitro and in vivo
aggregation of CRABP 1 were explored. Here, CRABP 1 will be presented as an
excellent model to study aggregation revealing conserved residue stretches that drive
aggregation in vitro and in vivo. Furthermore, our findings will illustrate how critical amino
acid segments expose mechanistic linkages between folding and aggregation of CRABP
1. In Chapter 3, we will present extensive work done to characterize the molecular basis
of aggregation of CRABP 1 under native conditions. This chapter will describe findings
supporting intimate connections between a low-population intermediate closely
resembling the functional conformation and the tendency to aggregate. We will also
describe existing intrinsic and extrinsic protection mechanisms against protein
aggregation. The final chapter will provide a summary of what we have learned about
the aggregation mechanism of CRABP 1 under native conditions, its implications in the
cellular context, and further discuss directions currently being undertaken to explore the
entire aggregation energy landscape of CRABP 1.
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CHAPTER 2

AGGREGATION SEQUENCE DETERMINANTS: IMPLICATIONS FOR FOLDING OF
A β-RICH PROTEIN
This chapter describes results of collaborations with Anastasia Zhuravleva, Ivan Budyak,
Beena Krishnan, Annie Marcelino and Lila Gierasch [Publication: Budyak I.L., Krishnan
B., Marcelino-Cruz A.M., Ferrolino M.C., Zhuravleva A. & Gierasch L.M. (2013) Early
Folding Events Protect Aggregation-Prone Regions of a β-Rich Protein. Structure 21:
476-485.

2.1. Introduction
Competition between folding and aggregation is imminent in proteins with rugged
energy landscapes such as β-sheet rich proteins. β-sheet rich proteins have complex
topologies and exhibit high degrees of energetic frustration. Intracellular lipid binding
proteins (ILBPs) are a family of proteins with frustrated energy landscapes yet have not
been implicated in any misfolding diseases (Budyak, et al., 2013). Over the past
decades cellular retinoic acid binding protein (CRABP 1), a member of the ILBP family
has been used as an excellent model to study the folding and aggregation of β sheetrich proteins (Liu, et al., 1994, Clark, et al., 1996, Clark, et al., 1997, Clark, et al., 1998,
Eyles, et al., 1999, Rotondi & Gierasch, 2003, Ignatova & Gierasch, 2004, Ignatova &
Gierasch, 2005, Ignatova & Gierasch, 2006, Marcelino & Gierasch, 2008, Ignatova &
Gierasch, 2009, Budyak, et al., 2013). However, similar to other proteins, a link between
these two distinct overlapping processes is not yet established. This chapter will present
findings from the experiments we carried out with an aim to fill the gap in knowledge
between folding and aggregation of CRABP 1. We will show common sequences in our
model protein that are critical for both folding and aggregation. Furthermore, we will
demonstrate how in the case of CRABP 1 physico-chemical properties required for
aggregation in vitro are maintained in vivo and validate predictions offered using several
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aggregation algorithms. Finally, this chapter will create an integrated picture describing
how key sequence features in CRABP 1 that direct aggregation are protected early by
folding.

2.1.1. Structure, Function and Dynamics of CRABP 1
CRABP 1 is a 136-residue β-sheet-rich protein and a member of the ILBP family.
Its proposed role in the cell is to control the nuclear uptake of retinoic acid at different
stages of development (Donovan, et al., 1995). Like other ILBPs, CRABP 1 has a βbarrel structure made up of two orthogonal five stranded β-sheets with an open angle
between and two helices that connect strands 1 and 2 (Kleywegt, et al., 1994,
Thompson, et al., 1995) (Figure 2.1). Except for strands 5 and 6, which are connected
by a variable Ω-loop, other β-strands are linked by short reverse turns (Kleywegt,
Bergfors et al. 1994). A hydrogen bond ladder stabilizes the β-strands in the barrel and
is broken between strands 4 and 5 (Thompson, Bratt et al. 1995). Like other ILBPs, it
forms a ligand binding solvent-shielded cavity filled with ordered water (Kleywegt, et al.,
1994, Thompson, et al., 1995). Retinoic acid is sequestered in the barrel by hydrophobic
interactions with helix 2, turn 2 (between strands 3 and 4), turn 4 (between strands 5 and
6) and polar interactions at the innermost cavity making the barrel almost inaccessible
(Kleywegt, et al., 1994, Li, 1999). The helix-turn-helix structural motif acts as lid that
opens up a dynamic portal between turns 2 and 4, allowing ligand entry and egress
(Thompson, et al., 1995, Krishnan, et al., 2000, Xiao & Kaltashov, 2005). Binding of
retinoic acid reduces the dynamics of this portal and locks the ligand inside the protein.
In chapter 3, we will discuss the structurally dynamic behavior of CRABP 1 and other
ILBPs that engages in ligand binding.
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Figure 2.1. Two projections of the structure of cellular retinoic acid binding
protein 1 (CRABP 1) bound to retinoic acid. CRABP 1 consists of two anti-parallel five
stranded β-sheets forming a large ligand binding cavity and connected by a helix-turnhelix motif. Turn II connecting strands 3 and 4 and turn 4 which links strand 5 and 6
interact with the helical region and form the ligand portal site. (PDB ID: 1CBR )
(Kleywegt, G. J., T. Bergfors, et al. (1994). "Crystal structures of cellular retinoic acid
binding proteins I and II in complex with all-trans-retinoic acid and a synthetic retinoid."
Structure 2(12): 1241-1258)
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2.1.2. Folding and Aggregation of CRABP 1
CRABP 1 has been used as a suitable model protein for understanding the
folding and aggregation landscapes of β-sheet proteins (Clark, et al., 1998, Ignatova &
Gierasch, 2005, Ignatova, et al., 2007). CRABP 1 like other ILBPs has a rugged folding
landscape, which has been described over the years using a wide array of biophysical
techniques such as intrinsic tryptophan fluorescence, ANS binding and circular
dichroism methods (Clark, et al., 1996, Clark, et al., 1997, Clark, et al., 1998). CRABP 1
folds via three well-defined kinetic phases. The initial phase is characterized by a rapid
hydrophobic collapse (τ=250 µs) where local segments of chain adopt significant
secondary structure (Clark, et al., 1997). This is followed by the establishment of specific
interactions that restrict the arrangement of the chains into a native topology (τ=100
ms)(Clark, et al., 1998). The final phase (1s) consists of specific packing of the β-sheet
side chains and formation of stable inter-strand hydrogen bonding (Clark, et al., 1998)
(Figure 2.2).

As mentioned earlier despite the high beta sheet content and the ruggedness of
folding landscapes, CRABP 1 and other ILBPs have not been associated with any
misfolding diseases. This observation implies that this class of proteins may have
evolved this robust folding mechanism with built-in aggregation protection (Budyak, et
al., 2013). Although CRABP 1 is found to be a successful folder, we have the capacity to
explore its aggregation landscape by introduction of single residue substitutions on
CRABP 1 or by modest alterations in solution conditions (addition of low concentrations
of denaturant or at slightly acidic pH). Previously, it has been found that in vitro and upon
overexpression in E. coli, CRABP 1 mutants form amorphous aggregates containing βlamellar structures with 10.03Å spacing between adjacent beta-sheets as revealed by
wide-angle X-ray scattering (WAXS) (Ignatova & Gierasch, 2004, Ignatova, et al., 2007).
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CRABP 1 folding and aggregation in E. coli have been monitored using a realtime fluorescence labeling method (Ignatova & Gierasch, 2004). This strategy involves
incorporation of structurally non-perturbing, specific tetra-Cys binding site for a bisarsenical fluorescein-based dye FlAsH that reports the folding and solubility of the
protein (Ignatova & Gierasch, 2004). Using this approach, aggregation of various
CRABP 1 mutants was monitored (Z. Ignatova & L. Gierasch, unpublished). Aggregation
of a slow-folding CRABP 1 mutant (Ignatova & Gierasch, 2005) showed similarities to
amyloids, following a nucleation-dependent polymerization requiring the formation of an
energetically unfavorable nucleus. (Ignatova & Gierasch, 2005, Ignatova, et al., 2007).
However, we have not yet fully understood the molecular basis of aggregation
propensity of CRABP 1. With the growing number of aggregation-prone mutants of
CRABP 1 being identified in the lab, we have been equipped to explore sequences that
determine the tendency of CRABP 1 to aggregate (Z. Ignatova and L. Gierasch,
unpublished). In the following section, we will describe hydrogen exchange experiment
we have utilized to identify regions sequestered in CRABP 1 aggregates.
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Figure 2.2. Folding pathway of CRABP 1. The proposed folding pathway for CRABP 1
proceeds through an early hydrophobically collapsed to form intermediate, I1 (τ=
~250 µs); followed by formation of I2 which has the native topology and ligand binding
cavity (τ= ~100 ms); and then by establishment of a hydrogen-bonding network and
specific tertiary interactions to form the native state, N (τ= ~1 s).
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2.1.3. Hydrogen-Deuterium Exchange NMR to Map Aggregation Cores
Short segments of a protein of at least five amino acid residues are sufficient to
form ordered aggregates (Chiti, et al., 2003, Fernandez-Escamilla, et al., 2004). These
segments have strong propensities to exhibit cross-β structures in aggregates and are
highly occluded from the environment (Hoshino, et al., 2002, Frare, et al., 2006).
Aggregation core sequences have been identified experimentally using methods that
probe for solvent accessibility as well as protease resistance (Hoshino, et al., 2002,
Frare, et al., 2006, Wang, et al., 2008, Vilar, et al., 2012). Amide hydrogen deuterium
exchange (HX) has been used to map core segments of β2m (Hoshino, et al., 2002),
transthyretin (Olofsson, et al., 2004), Aβ peptide (Kheterpal, et al., 2006) amyloids as
well as of bacterial inclusion bodies (Hoshino, et al., 2002, Olofsson, et al., 2004,
Kheterpal, et al., 2006, Vilar, et al., 2012). This method sensitively probes for highly
ordered regions of the protein molecule forming amyloid fibrils at amino acid residue
resolution. In this thesis we have successfully employed hydrogen exchange in resolving
aggregation core sequences of CRABP 1.

Hydrogen deuterium exchange measures the rate of exchange between the
amide hydrogen in the polypeptide backbone and deuterium in the solvent. Exchange
rates can be monitored using available methods that can distinguish between proton and
deuterium such as nuclear magnetic resonance (HX-NMR) and mass spectrometry (HXMS) (Scholtz & Robertson, 1995, Hoofnagle, et al., 2004). Measurements of exchange
rates can unveil the presence or absence of protecting structure thus are valuable in
determining thermodynamic stability, studying protein dynamics and following protein
folding (Eyles & Kaltashov, 2004, Krishna, et al., 2004). Amide hydrogens in an unfolded
polypeptide are labile and exchange readily with the solvent. On the other hand, in
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folded proteins where secondary and tertiary structures prevail, exchange is retarded by
H-bonding networks or by burial of hydrophobic residues in the core of a protein. The
extent of protection from exchange in the folded protein correlates with the degree of
ordered structures.

Hydrogen exchange consists of two steps: First is the exposure of backbone
amides to the solvent by reversible unfolding of the protein. Second is exchange
between deuterium from the solvent and the exposed amide protons. The overall
exchange kinetics are governed by both reactions.

NHc and NHo represent the amide groups in the “closed” (folded) and “open” (unfolded)
ND is the exchanged amides; The measured exchange rate kex is determined by the
opening ko, closing kc rate constants and the expected rate of exchange assuming the
site is completely exposed, kint. The relationship is shown as:

Under conditions where HX is generally performed, the kc >>ko to approximate
the previous equation as:

There are two extreme limits of exchange EX1 and EX2. The first case is when kc
>> kint, an behavior expected at low pH and temperature, the exchange rate becomes:
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where Ko = ko/kc. This is an EX2 or bimolecular exchange limit. A heterogeneous pattern
of exchange results from incomplete exchange at all sites. The second case is when kc
<< kint, all protons in the unfolded segment will exchange, in this case, unfolding of the
protein is a rate-limiting step thus,
kex =ko
This limit of exchange is referred to as EX1 or monomolecular exchange. EX1
appears as a bimodal pattern with all amides either exchanged or unexchanged. This is
usually observed at high pH and temperature the exchange reaction rate is limited by the
opening event of the amide site.

Hydrogen exchange combined with high-resolution NMR spectroscopy provides
detailed information on the structure and thermodynamic stability of proteins at residuespecific resolution. This method has been widely applied in probing various
conformational states of proteins, including denatured states, and equilibrium or kinetic
folding intermediates with complex three-dimensional structure (Hoshino, et al., 2007). A
typical HX-NMR experiment requires high concentrations of proteins in solution and an
appropriate NMR measurement is recorded. Cross-peak intensities used to detect amide
protons such as

1

H-15N heteronuclear single quantum correlation (HSQC) directly

correlates with the occupancy of amide protons. Exchange rates are determined by
monitoring the decrease in peak intensity in the spectrum. A single exponential decay
plot of peak intensity as a function of exchange time is generated as described in the
equation:
I(t) = I(0) exp(−kext)
where t is the exchange time, I(0) and I(t) are peak intensity at time zero and time t,
respectively, and kex is the exchange rate constant.
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In a hydrogen exchange experiment protein samples are incubated in a
deuterated solvent for a period of time followed by a quenching reaction at low pH and
temperature. At low temperatures and pH, the rates of exchange are reduced preventing
back exchange in deuterated amides. HX detection using solution NMR poses inherent
limitation on the apparent size of the target protein in which signal is approximately
inversely proportional to the molecular weight of the protein (Hoshino, et al., 2007). Line
width broadening of NMR signal results from increase in rotational correlation time as
molecular weight of the protein increases. Since the line widths are infinitely broadened
for supramolecular complexes, direct measurement of NMR spectrum is impossible.
Nevertheless, a modified hydrogen exchange NMR method has been developed to
study the structural and dynamic properties of β-microglobulin and cold shock protein A
(CspA) aggregates (Alexandrescu, 2001, Hoshino, et al., 2002). Despite the fact that this
does not offer information about the geometric constraints of the aggregates, it provides
details on structural reorganizations in the native protein accompanying aggregation
(Vilar, et al., 2012). In addition it also allows identification of peptide segments involved
in the formation of secondary structures that stabilize aggregates (Vilar, et al., 2012). An
indirect HX technique uses an organic aprotic solvent dimethyl sulfoxide (DMSO) to
quench exchange and dissolve aggregates in solution to permit analysis by solution
NMR (Hoshino, et al., 2007). At very high DMSO concentrations, aggregates are
dissolved into monomers within the dead time of NMR measurements (Hirota-Nakaoka,
et al., 2003). The exact oligomeric state of the protein in DMSO is not known however no
difference in line widths in the NMR spectra is evident between the monomer and
dissolved aggregates (Hoshino, et al., 2007).

The rate of exchange in DMSO is 100-fold lower in 90-95% DMSO than in water
(Zhang, et al., 1995). Furthermore, pH dependent exchange is different in water and in
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DMSO shifting the minimum from pH 3 to pH 5 (Zhang, et al., 1995). In DMSO,
formation of deprotonated amide necessary in the base-catalyzed exchange is
unfavorable resulting in this pH minimum shift (Zhang, et al., 1995). This also shifts the
pKas of acids to a great extent whereby strong acids in aqueous solutions such as
dichloroacetic acid (DCA) and trifluoroacetic acids may act as buffers in DMSO (Zhang,
et al., 1995). DMSO not only dissolves aggregates but also offers as a solvent without
labile hydrogens that may cause back-exchange. At high DMSO concentrations,
solubilized proteins are denatured thus amide proton exchange for each residue is
susceptible to exchange with trace water in the solvent. However, the rates of backexchange is reduced in high DMSO solvents thus permits acquisition of multiple HSQC
spectra for analysis (Hoshino, et al., 2007).

The steps for DMSO-quenched hydrogen exchange are as follows: 1)
Preparation of aggregates in aqueous solution; 2) incubation of aggregates in deuterated
buffer; 3) collection of aggregates at various exchange times; 4) exchange quenching
and dissolution of aggregates at high (>95%) concentrations of DMSO-d6 at an
appropriately adjusted pH value; 5) acquisition of two-dimensional NMR spectra
successively to detect resonance signals from remaining protonated residues (Hoshino,
et al., 2007).

Several factors may interfere with this experiment. First is the fact that DMSO is
an aprotic and hygroscopic solvent it is difficult to maintain pH and to prevent water
contamination (Hoshino, et al., 2007). In addition even if water is completely eliminated,
internal exchange between amide protons of residues may complicate the experiment
(Hoshino, et al., 2007). To minimize the effect of water contamination it is recommended
that 95% (v/v) DMSO-d6 and 5% (v/v) D2O at pD 5 adjusted by DCA-d2 be used as a
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quenching buffer for the exchange reaction. The presence of residual exchange in 5%
(v/v) of D2O is not expected to complicate the experiment as long as the rate of
exchange and water contamination is very minimal (Hoshino, et al., 2007).

2.2. Results
2.2.1. Aggregation Propensity of CRABP 1
In our study, we have used a stabilized variant of CRABP 1, WT* containing
R131Q mutation. Mutation of Arg 131 breaks the charged interactions between retinoic
acid leading to less affinity to the ligand (Zhang, et al., 1992). This variant has been
previously used in understanding the folding landscape of CRABP 1 (Clark, et al., 1996,
Clark, et al., 1998, Eyles, et al., 1999, Eyles & Gierasch, 2000, Marcelino & Gierasch,
2008). While this mutant has a lower ligand binding affinity, it is more thermostable and
highly soluble when over-expressed in E. coli. Thus, WT* CRABP 1 serves as a suitable
background to monitor effects of residue substitutions or solution conditions on
aggregation propensity.

Using several available aggregation prediction algorithms namely, AGGRESCAN
(Conchillo-Sole, et al., 2007, de Groot, et al., 2012), TANGO (Fernandez-Escamilla, et
al., 2004), PASTA (Trovato, et al., 2006) and Zyggregator (Tartaglia & Vendruscolo,
2008) aggregation hotspots in CRABP 1 were predicted (Appendix A). Predictions varied
only slightly from one algorithm to another, as aggregation prone regions are usually
predicted by at least two algorithms. Aggregation propensity scores have been
consistently high in strands 3, 4, 9 and 10 and helix II (Figure 2.2a).

32

Figure 2.3 Predicted aggregation-prone regions of CRABP 1.
A) Predicted aggregation-prone regions using Zyggregator, AGGRESCAN, TANGO
and PASTA mapped on to the sequence of CRABP 1.
B) Aggregation-prone regions projected on to the structure of CRABP 1. Sequences
predicted by at least two algorithms are painted in green. Sequences predicted by
only one algorithm are painted in blue. All predictors identified the C-terminal
strands to be aggregation prone.
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WT* CRABP 1 can be overexpressed as soluble protein in E. coli, but we found a
number of single residue substitutions that result in different extents to aggregate (Table
2.1. The aggregation propensities of CRABP 1 variants were determined using cell
fractionation method. This was accomplished by overexpressing mutant protein in
BL21(DE3) E. coli strains at 37oC for 3 hours and then lysing the cells using a
commercially available mild non-ionic detergent. Initial experiments to test the
reproducibility of cell disruption techniques revealed that optimal lysis can be achieved
without breaking the aggregates using this mild detergent as compared to sonication and
freeze thaw methods. Following cell disruption, lysates were separated into supernatant
and pellet fractions and run on an SDS-PAGE. The distributions between the soluble
and pellet fractions of the protein were quantified by measuring the optical densities of
protein bands corresponding to CRABP 1 and taking the ratio of the optical densities of
the pellet and soluble fractions with respect to the lysate fraction (Table 2.1).

To test whether aggregation propensities of the CRABP 1 mutants can be
predicted, we again employed the aggregation predictors. We have found that except for
a couple of mutants, aggregation predictors did not distinguish aggregation propensities
between CRABP 1 variants with very different experimental aggregation propensities. An
example is the case of F71A, which is a mutation in strand 5 and involved the
hydrophobic core network of CRABP 1. We experimentally find this mutant to be highly
aggregation-prone since it can only be expressed as inclusion bodies. However, all the
aggregation predictors did not show any increase in aggregation propensity for this
mutant. We also found a couple of mutations, which emerged to affect the predicted
aggregation propensity of CRABP 1. These include mutations I52A and L118V.
isoleucine 52 is found in strand 3 and leucine 118 is found in strand 9 (Appendix B).
I52A substitution had a lower overall predicted aggregation propensity resulting from a
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decrease in CRABP 1 β-propensity and hydrophobicity attributed to the substitution of
isoleucine to alanine (Appendix C). However, in contrast to predictions, compared to the
WT protein, I52A mutant was completely insoluble upon overexpression in E. coli (Table
2.1). In the case of L118V the substitution increased the hydrophobicity of the protein
thus a higher aggregation propensity was predicted (Appendix D) Experimentally, we
find L118V is moderately (~50% soluble after 3 hours of protein overexpression)
aggregation-prone in comparison to WT CRABP 1 (Table 2.1). Examination of
aggregation propensities of CRABP 1 mutants suggests that effects of single amino acid
substitutions on globular proteins cannot be sensitively predicted based solely on protein
sequence. Other factors such as thermodynamic stability and structural fluctuations
inherent for different proteins, which dictate the exposure of aggregation-prone
sequences must be integrated in models to forecast aggregation propensities.
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Table 2.1. Aggregation propensities and thermodynamic stabilities of CRABP 1
variants
∆∆GU-N (energetic effect of mutations on the free energy of the unfolded state (U) with
respect to the native state (N)) = ∆GU-NWT - ∆GU-NMutant
Aggregation propensities were determined based on partitioning of the protein into
soluble and insoluble fractions after overexpression in E. coli for 3 hours at 37oC.
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2.2.2. Sequestered sequences in CRABP 1 in vitro and in vivo aggregates
In order to find significance in our experiments, we first explored how aggregation
in vitro compared in vivo. Thus we performed experiments to compare morphologies and
molecular interactions stabilizing in vitro and in vivo aggregates. To inspect the
morphologies of the in vitro and in vivo aggregates, transmission electron microscopy
(TEM) was performed. Inclusion bodies were purified from washing the cell pellet with
non-ionic detergent and treating with lysozyme and DNase. To yield in vitro aggregates,
aggregation-prone F71A CRABP 1 mutant proteins isolated from inclusion bodies were
refolded from high urea concentrations into buffer without urea at pH 7.0 containing 150
mM NaCl and 5 mM DTT at 37oC. Insoluble aggregates were formed during refolding of
aggregation-prone mutants at high concentrations (above 50 µM) under these
conditions. Aggregates generated under these different conditions appeared amorphous
and non-fibrillar consistent with previous observations (Ignatova & Gierasch, 2005).
Although both were amorphous, the morphologies were different. In vivo, CRABP 1
forms uniform globular aggregates while aggregate formed in vitro did not (Appendix E).

To interrogate whether there are contiguous sequences sequestered in these
amorphous aggregates and whether they are consistent with predicted aggregation
hotspots, aggregate cores of both in vitro and in vivo aggregates were mapped. Using
DMSO-quenched hydrogen deuterium exchange NMR as an approach, aggregation
cores of in vitro aggregates and inclusion bodies of CRABP 1 mutants were determined.
15

N-labeled in vivo aggregates of F71A mutant were isolated using a non-ionic

detergent. We estimated the purity of the inclusion bodies to be around 80-90%
(Appendix F). Previous reports on the quality of purified inclusion bodies revealed that
although inclusion bodies generally consist of overexpressed recombinant proteins, a
small fraction of contaminating proteins are present (Ventura & Villaverde, 2006). These
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include proteolytic fragments of the recombinant protein, molecular chaperones such as
small heat-shock proteins (IbpA and IbpB), DnaK and GroEL (Ventura & Villaverde,
2006, Dasari, et al., 2011). Purified CRABP 1 inclusion bodies were tested for the
presence of molecular chaperones DnaK and small heat shock protein, IbpA by western
blot. Purified inclusion bodies from several aggregation-prone CRABP 1 mutants did not
show presence of DnaK but were positive for IbpA (Appendix G).

Isotopically-labeled proteins in inclusion bodies and in in vitro aggregates for
NMR studies were prepared as previously mentioned. Aggregates were exchanged in
D2O for four weeks to determine the highly protected cores. Incubation was performed
for four weeks to ensure exhaustive exchange. Reactions implemented at different time
intervals showed that no significant exchange occurs after four weeks. Aggregates were
collected, lyophilized and resuspended in DMSO-d6 containing 0.1% (v/v) trifluoroacetic
acid (TFA), 50 mM DTT and 5% (v/v) D2O (pD 3.0-3.5) to a final protein concentration of
200 µM. Quench reactions were done at pD=3.0-3.5 1H-15N HSQC NMR experiments
were performed to monitor amide protons. We performed our experiments in buffers with
pD=3.0 to 3.5 instead of pD=5.0, the condition suggested by Hoshino and Goto that
minimizes back-exchange, since we find less pH-dependent chemical shifts under this
condition. We performed backbone residue assignments using purified

13

C/15N-labeled

WT* CRABP 1 dissolved in quench buffer. We observed a narrow and crowded 2D
spectrum with a number of overlapping peaks. Hence, we added another dimension by
performing several triple-resonance NMR experiments to resolve individual residues.
Backbone assignments were transferred to the spectra of the mutant protein and
adjusted accordingly for any shifts associated with the mutations. Figure 2.4 shows a
typical HSQC spectra of mutant CRABP 1 aggregates dissolved in DMSO. In total 128
out of 158 amino acid residues (around 80%) have peaks assigned. NMR spectra for
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both in vitro and in vivo aggregates were compared before and after exchange. For
controls, the unexchanged samples were incubated in water for the same amount of
time and quenched under the same conditions as in the exchanged samples. It is worth
mentioning that aggregates remained stable even after long periods of incubation in
either water or D2O. We have also performed initial control experiments to monitor backexchanges to determine the duration for data acquisition by taking HSQC measurements
of unexchanged aggregates every hour over a 24-hour period. We found little backexchange if measurements were performed within two hours after dissolution of
aggregates in DMSO. In our experiments, our data acquisitions were completed within
30 minutes after dissolving the aggregates.
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Figure 2.4. 1H15N HSQC Spectra of F71A CRABP 1 before and after hydrogendeuterium exchange. The NMR spectrum before exchange (left), shows several
intense peaks with their residue assignments. On the right is the NMR spectrum after
exchange showing less peaks. These remaining peaks correspond to the aggregation
cores.
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A comparison of the acquired HSQC NMR spectra from in vivo and in vitro
aggregates revealed that in vivo aggregates contained additional peaks not originating
from CRABP 1 (Figure 2.5). These peaks may be attributed to the presence of
contaminating proteins in the inclusion bodies. As we have mentioned earlier, we found
a small percentage of other proteins in our samples. Additional peaks have also been
observed in HSQC spectra of inclusion bodies from other proteins (Dasari, et al., 2011).

As we expected, both in vitro and in vivo aggregates had only few but strong
peaks remaining after exchange. Individual residues corresponding to intense peaks
after exchange were identified. For in vitro aggregates, residues 51-65 with the
exception of serine 55 (core 1), 119-123 (core 2) and 127-134 (core 3), were extremely
protected (Figure 2.5). A comparison of aggregation core sequences with predictions
correlated very well with predicted aggregation hotspots (Figure 2.6). Except for residues
along the helical domain, we were able to observe high solvent protections in β-strands
predicted by the different algorithms. Core 1 is located in the strand 3, turn II, and strand
4 while cores 3 and 4 are situated in strands 9 and 10 respectively (Figure 2.7).
Surprisingly the exact same regions of CRABP 1 were found for the in vivo aggregates.
Backbone amides of residues 52-64, 120-123 and 127-134 remain protonated.

To check whether the same sequences form the aggregation cores for other
mutants, hydrogen exchange NMR experiments were also performed on L118V and
I52A CRABP 1 inclusion bodies. All mutants contained highly protected residues and
were consistent with those identified for F71A mutant (Figures 2.5). It is interesting that
although both mutants are found close to two different aggregation cores, there was no
preference for aggregation cores close to the mutation.
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Figure 2.5. HSQC spectra of CRABP 1 inclusion bodies before and after hydrogen
exchange. Inclusion bodies from moderately aggregation-prone mutant L118V (left) and
highly aggregation-prone mutants F71A and I52A (center and right) were allowed to
exchange in D2O containing 0.025% NaN3 for four weeks. Inclusion bodies were
dissolved in DMSO-d6 containing 0.1% TFA and 5 mM DTT. Mutants of CRABP 1
contain similar aggregation core segments as revealed by similar peaks remaining after
exchange.
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Figure 2.6. Experimentally determined and predicted aggregation-prone regions
of CRABP 1. Aggregation cores of CRABP 1 determined by hydrogen exchange
mapped against the amino acid sequence. Also aligned with the sequences are the
predicted aggregation segments. These cores were consistent to predictions
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Figure 2.7. Aggregation cores of CRABP 1.
Aggregation-prone segments mapped on the structure of CRABP 1 (orange highlights).
Aggregation cores are found at strands 3, 4, 9 and 10 and in turn 2 of CRABP 1.
Indicated in the structure are the locations of the mutations: Phe71 (blue); Ile52 (red)
and Leu118 (green).
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To verify whether the very slow exchange behavior of the aggregation cores is
distinct from the other residues, residual peak intensities from triple resonance HNCO
experiments were compared at different time points. In order to minimize acquisition
time, sparse HNCO experiments (Orekhov, et al., 2003, Jaravine, et al., 2008). Sparse
3D experiments applies non-Fourier transform methods for analysis and non-uniform
sampling to minimize data acquisition time while maintaining good resolution. HNCO
experiments were performed on I52A CRABP 1 inclusion bodies exchanged at varying
time intervals. Intensities of individual, non-overlapping peaks were determined and
plotted with time (Figure 2.8). We did not extract thermodynamic parameters from our
quantitation since the peak intensities had low signal to noise ratios. However, we were
able to classify residues based on two types of behaviors; fast and slow exchanging
residues. In fast exchanging residues, we observed a rapid decrease in intensity within a
few hours of exchange and after two weeks, signals have deceased at least five-fold
(Figure 2.8). However, for slow exchanging residues, signal intensities decrease slower
and still contain at least 30% of their intensities after two weeks of exchange.
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Figure 2.8. HNCO peak intensities of CRABP 1 residues from aggregates
exchanged over time
A) Peak intensities obtained from sparse HNCO spectra (each spectra were recorded for
less than 2 hours to minimize H/D exchange during experiments of highly aggregationprone CRABP1 mutant I52A aggregates in 95% d6-DMSO/5% D2O for the
unexchanged sample (red) and samples that were H/D-exchanged (yellow) for 6 hours
(top) and 2 weeks (bottom). All assigned residues those peaks have signal-to-noise ratio
more than 10 (and errors in peak intensities more than 10%) for the unexchanged
sample were used for analysis. Resonances for residues from the aggregation core(s)
(middle and right) retained significant (30-60% from intensities for the unexchanged
sample) intensities after 2 weeks of exchange, while intensities for the rest resonances
(with exception of Phe3) decreases in more than 5 times (left).
B) Relative peak intensities as a function of H/D-exchange time, I(exch)/Io×100%, where
I(exch) and Io are peak intensities for residues shown on (A) [with exception of Phe3, the
quality of data for this residue is too noisy for analysis] obtained from H/D-exchanged
and unexchanged samples, respectively. Residues from the aggregation cores (shown
in blue) have a significantly slower decay for relative peak intensities as comparing with
the rest protein (red); while behavior of the (different) aggregation core(s) are similar
within experimental errors (10-20%).
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B)
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2.3. Discussion
2.3.1. Common Sequences Direct Aggregation of CRABP 1
Protein folding and aggregation are driven by similar amino acid properties such
as hydrophobicity, secondary structure propensity and charge. Thus, competition
between intramolecular and intermolecular interactions, which direct folding and
aggregation respectively, is inevitable. However, the balance between folding and
aggregation can be shifted under defined conditions allowing a plethora of independent
mechanistic studies. This study aims to make a connection between folding and
aggregation to provide a comprehensive picture that will illustrate the fate of a
polypeptide chain. Here, sequence determinants that link folding and aggregation of a βprotein were described. In addition, we demonstrated the specificity of aggregation by
comparing aggregate structures of various mutants generated in vitro and in vivo.

CRABP 1, a β-clam protein whose folding mechanism has been studied in detail
was used as a model. Owing to their rugged folding energy landscapes with high degree
of frustration, multiple intermediate states and increased propensity to aggregate,
predominantly β-sheet proteins are an apt structural class for examining molecular
details of the balance between folding and aggregation. CRABP 1 folds via two
intermediate states an early collapsed state (I1) and a later β-molten globule-like state
with native topology (I2) – and thus exemplifies β-barrel frustration (Clark, et al., 1996,
Clark, et al., 1997, Clark, et al., 1998). Despite this, CRABP 1 and members of its class
fold and avoid aggregation efficiently. To study how CRABP 1 protects itself from
aggregation, we mapped sequences that are sequestered in aggregates. As we discover
the role of these sequences in folding of CRABP 1 from previous studies we were able
to find clear links to aggregation.
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First we interrogated whether aggregation is specific by comparing the molecular
characteristics of in vitro and in vivo aggregates of CRABP 1. We initially developed
protocols to generate in vitro and in vivo aggregates. For in vitro aggregates we aimed to
produce aggregates that will simulate how proteins aggregate in cells but in the absence
of other complexities such as a crowded environment and other cellular machineries
such as molecular chaperones and proteases. An aggregation-prone mutant F71A was
overexpressed as inclusion bodies and purified in high urea. With the protein denatured
in urea, it mimics an unfolded nascent chain. From a highly denaturing environment, the
protein was refolded into native-like buffer conditions. During this process, depending on
the initial protein concentration, a significant amount of aggregates are formed permitting
us to analyze its structure. To generated in vivo aggregates, the mutant protein was
overexpressed as inclusion bodies and purified using a mild non-ionic detergent. Using
this method, cell lysis was efficient yet inclusion bodies remained intact. As mentioned in
the previous section, several other proteins co-aggregated with CRABP 1. We have
noted the presence of small heat shock protein IbpA. Small heat shock proteins IbpA
and IbpB bind to aggregated proteins and change their physical properties to mediate
disaggregation and refolding by chaperones (Ratajczak, et al., 2009). Aggregates
derived in vitro and in vivo were strikingly different in morphologies. In vitro aggregates
appeared heterogeneous with no distinct shape while inclusion bodies had the typically
observed round shaped structures (Ignatova & Gierasch, 2005, Morell, et al., 2008). It
appears that in a crowded cellular environment, aggregation of proteins is confined in
space giving rise to compact inclusions. An interesting aspect to further explore is the
potential role of bound small heat shock proteins in modulating aggregate morphologies
and molecular structures in cells.
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To characterize the interactions that stabilize aggregates, DMSO-quenched
hydrogen exchange was performed and monitored using solution NMR. The use of this
protocol allowed us to resolve regions of protein sequestered from the solvent in
aggregates. DMSO dissolved in vitro aggregates almost instantly while inclusion bodies
were only partly soluble. A small percent of the inclusion bodies, which may be nonprotein components, was insoluble in DMSO. However, these did not interfere with the
analysis. Dissolution of aggregates in DMSO provided high sensitivity allowing us to
study consecutive regions of CRABP 1 extremely resistant to solvent exchange by NMR.
Analysis of the aggregates derived under extremely diverse conditions revealed
common sequence motifs that drive aggregation. These sequences correlated to a high
extent with that of predicted aggregation hotspots. These suggests that the physicochemical properties of protein sequences as evaluated by several aggregation predictors
dictate the potential to be sequestered in aggregates. The identical sequences in
aggregation cores in vitro and in vivo supports the idea that although aggregation
involves interaction between hydrophobic patches it is specific even under extremely
variant conditions. In separate reports, it has been shown that inclusion bodies, although
amorphous, have high specificity similar to highly ordered amyloid structures (de Groot,
et al., 2008, Morell, et al., 2008, Wang, et al., 2008). Thus inclusion bodies have been
proposed to be useful models for intermediates in amyloid formation (Dasari, et al.,
2011).

To further investigate whether other aggregation-prone mutants contain the same
core structures, L118V and I52A CRABP 1 mutants were also tested. L118V has a high
predicted and moderate experimental aggregation propensity. However, I52A has a
lower predicted aggregation propensity but was highly aggregation-prone. Leu118 is
close to aggregation core 2 and Ile52 is in core 1 based on the core sequences identified
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on F71A CRABP 1 mutant. Using the same hydrogen exchange method, the
aggregation cores determined in these mutants corresponded to the same amino acid
stretches determined for F71A mutant. These suggest that the population of common
aggregation-prone intermediate/s that expose the same consensus sequences dictates
the extent of aggregation of CRABP 1. In the following chapter, we will describe
experiments performed to resolve the aggregation-prone intermediate of CRABP 1
under native conditions.

2.3.2. Common Sequence Motifs Drive Aggregation and Folding of CRABP 1
An extensive study on the early events in folding of CRABP 1 was done in
parallel with this study (Budyak, et al., 2013). In this study single residue substitutions at
33 sites were introduced in the CRABP 1 sequence with comprehensive coverage of
structural elements including the minor hydrophobic core near the barrel closure region
(Budyak, et al., 2013). The observed impact of these mutations on CRABP 1 stability
and unfolding kinetics revealed that its rate-determining transition state (TS) is highly
polarized (Budyak, et al., 2013). It showed that the barrel closure interactions formed
before the TS, and interactions in the major hydrophobic core developing only after the
TS (Budyak, et al., 2013). Barrel closure of CRABP 1 involves partner interactions
between strand 10 and strand 1. It is speculated that the early docking and specific
interactions between these terminal strands help simultaneously assemble the front and
back sheets of the barrel assisting the rapid folding of CRABP 1 (Budyak, et al., 2013).

Consistent with the results on the folding studies, strand 10 was invariably
predicted to be an aggregation hotspot. Experimentally, we have also resolved these
regions of the proteins to be sequestered in the cores of aggregates. Strand 10 is a
typical edge strand, an interface that can transiently be exposed leading to aggregation
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(Richardson & Richardson, 2002, Soldi, et al., 2008, Chiti & Dobson, 2009). Early barrel
closure in the folding mechanism of CRABP 1 would protect strand 10 by providing a set
of partner interactions, thus mitigating its vulnerability as an unpartnered edge strand
(Budyak, et al., 2013). The aggregation core 2, involving strand 9 is also intrinsically
labile (Krishnan, et al., 2000, Xiao & Kaltashov, 2005) also becomes protected upon
closure of the barrel. Thus, taken together, it is hypothesized that protection of
aggregation-prone regions in CRABP 1 by structural features and barrel closure occurs
early in folding and significantly reduces its risk of aggregation. Our findings on a
common sequence motif in CRABP 1 that initiate folding and aggregation demonstrate a
clear connection between the two processes involving very distinct interactions. It is
argued in this case that folding involves protective mechanisms that may have evolved
to prevent aggregation. However, we also show that there is a very delicate balance that
can be shifted in either direction. The following chapter will demonstrate how despite
several protective mechanisms, local fluctuations in the native state can trigger
aggregation.

2.4. Experimental Procedures
Cell partitioning experiments
Variants of CRABP 1 were overexpressed until OD600=0.8 and protein expression
were induced for three hours at 37oC. Cells were lysed using bacterial protein extraction
reagent BPER II (Thermo Scientific) following manufacturer’s protocol. Lysates were
spun down at 20,000 for five minutes. After centrifugation, soluble and pellet fractions
were separated. Pellet fractions were dissolved 8M urea using equal volumes with the
soluble fractions. Soluble fraction and dissolved pellet were mixed SDS-loading dye and
boiled for five minutes then run on 12% Tricine SDS-PAGE. Protein bands were stained
with Coomassie blue and observed using a GelDoc system (Biorad). Distributions of
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CRABP 1 mutant proteins in each fraction were determined by taking the ratio of the
optical density of the band corresponding to CRABP 1 in both pellet and soluble
fractions with respect to the lysate fraction.

Expression and purification of proteins from inclusion bodies
CRABP 1 mutants were generated using a stabilized variant of murine CRABP 1
(WT* CRABP 1) (Clark, et al., 1998) and N-terminal (His)10-tag as background template
incorporated into a PET16b vector. Single residue substitutions were introduced into the
WT* CRABP 1 sequence by site-directed mutagenesis using a QuikChange protocol
(Stratagene). The WT* and mutant proteins were expressed in BL21(DE3) E. coli strain
(Novagen) either in Luria-Bertani media (non-isotopically labeled proteins) or M9
minimum media containing

15

NH4Cl and/or

13

C-glucose (for isotopically labeled proteins).

E. coli cells containing plasmids for WT* CRABP 1 were grown until OD600=0.7-0.8 and
protein expression was induced using 0.4mM IPTG for four hours at 30oC. To produce
CRABP 1 mutants as inclusion bodies, cells were grown at OD600=0.8-1.0 and
overexpressed at 37oC for four hours for non-isotopically labeled proteins and six hours
for isotopically labeled proteins. Cells were resuspended in lysis buffer (50 mM sodium
phosphate, pH 8.0, 300 mM NaCl) and disrupted using Microfluidizer M-110L processor
(Microfluidics). To purify soluble WT* CRABP 1, we collected the supernatant and ran on
a Ni-NTA agarose affinity column (Qiagen) at over an increasing imidazole gradient.
Fractions containing pure proteins were dialyzed in 10 mM ammonium bicarbonate and
lyophilized overnight. For proteins isolated from inclusion bodies, pellet fractions were
collected and resuspended in lysis buffer containing 8M urea. Protein solutions were
eluted on a Ni-NTA affinity chromatography column at room temperature using buffers
containing 8M urea with increasing imidazole concentrations. Absorbance at 280 nm
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was taken to determine the concentration of purified proteins and using the extinction
coefficient 21,294 M-1 cm-1.

Preparation of in vitro aggregates
To generate in vitro aggregates, fractions containing purified F71A CRABP 1
mutant in urea were dialyzed in 10 mM phosphate buffer pH 7.0 containing 150 mM
NaCl and 5 mM DTT at 37oC. Aggregates were collected from the dialysate by
centrifugation. To determine the concentration of proteins in aggregates, aggregates
were dissolved in 8M urea and concentrations were determined by taking the
absorbance at 280nm.

Purification of bacterial inclusion bodies
Inclusion bodies for these aggregation-prone mutant proteins were purified using
a non-ionic detergent, BPER II combined with lysozyme treatment. Purification of
inclusion bodies was performed following manufacturer’s instructions with slight
variations. The following procedures to purify inclusion bodies were performed in small
aliquots (15mL cell culture) for efficient separation of contaminants. Cells were collected
after centrifugation at 4,000 rpm for 10 min and resuspended in BPER II bacterial protein
extraction reagent (Thermo Scientific) at 1:10 (BPER II: bacterial growth culture) ratio.
The cell suspension was vortexed and centrifuged to collect the pellet. The pellet was
resuspended in the same volume of BPER II and treated with lysozyme (0.4mg/mL).
Pellet was washed with twenty-fold diluted BPER reagent. Wash steps were repeated
trice. Pellet was washed with 10 mM Tris-HCl pH 8.0 and then with distilled deionized
water. To check the purity of the inclusion bodies, these were resuspended in 8M urea
and ran on a 12% SDS-PAGE. In order to check the concentration of CRABP 1 mutants
in the aggregates, inclusion bodies were ran on an SDS-PAGE along with protein
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standards of known concentrations. Band intensities of standard proteins were taken to
generate a standard curve and from this, the concentrations of inclusion bodies were
determined.

Hydrogen exchange NMR of aggregates
We identified the aggregation core residues of CRABP 1 inclusion bodies using
hydrogen-deuterium (H/D) exchange and monitored by solution NMR spectroscopy as
described previously (Hoshino, et al., 2002). Briefly,

15

N/13C-labeled CRABP 1 inclusion

bodies of F71A, L118V and I52A CRABP 1 mutants were incubated in D2O for four
weeks at 4 °C. Aggregates were collected, lyophilized and then resuspended in d6DMSO containing 0.1% (v/v) TFA, 50 mM DTT and 5% (v/v) D2O (pD 3.0-3.5) to a final
protein concentration of at least 200 µM. The solution was immediately transferred to an
NMR tube, and the heteronuclear single quantum coherence (HSQC) spectrum was
recorded at 26 °C on a 600-MHz Bruker Avance spectrometer using a TXI cryoprobe.
For unexchanged samples, inclusion bodies were resuspended in water containing
0.025% (w/v) NaN3 and incubated at 4°C for four week. NMR data were processed using
NMRPipe (Delaglio, et al., 1995). Backbone assignments of CRABP 1 aggregates
dissolved in DMSO were obtained using a standard set of triple resonance experiments,
including HNCACB, CBCA(CO)NH, HBHANH, HNCO, and HNCACO.

Sparse 3D HNCO experiments were performed on DMSO dissolved inclusion
bodies initially incubated in D2O at different time points, using a 700-MHz NMR Varian
spectrometer. Relative peak intensities as a function of H/D-exchange time,
I(exch)/Io×100%, where I(exch) and Io are peak intensities for assigned residues were
determined.
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CHAPTER 3
PROTEIN AGGREGATION: BALANCE BETWEEN INHERENT DYNAMICS AND
FUNCTIONAL INTERACTIONS OF A β-PROTEIN

This chapter describes results of collaborations with Anastasia Zhuravleva, Ivan Budyak
and Lila Gierasch

3.1. Introduction
In order to function proteins have evolved to correctly self-assemble into their
three-dimensional native fold. In a protein’s energy landscape it is inevitable that the
multiple intermediate species populated prior to the native state may tip the balance
between folding and aggregation (Brockwell & Radford, 2007, Jahn & Radford, 2008). In
addition to this complexity, local fluctuations driving partial exposure of hydrophobic
stretches in the native state may precede aggregation (Bemporad, et al., 2012,
Neudecker, et al., 2012, Sabate, et al., 2012). Recently, it has been proposed that
functional interactions rather than folding primarily compete with aggregation (Masino, et
al., 2011, Pastore & Temussi, 2012). Over the past years, mechanisms of aggregation
have been studied on a few small globular proteins but no clear link between folding,
function and aggregation has been elucidated (Booth, et al., 1997, Villanueva, et al.,
2004, Yamaguchi, et al., 2004, Hamada, et al., 2009, Pagano, et al., 2010). It remains
very confounding how a protein is fine-tuned to favor protein stability and necessity to
function over aggregation. In this chapter, we interrogate the following: How does a
natively folded protein become susceptible to aggregation? How do functional
interactions counteract the risk of aggregation? What intrinsic and extrinsic protective
mechanisms help attenuate aggregation?
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These questions were addressed using our model protein CRABP 1 to examine
the complex balance between folding, aggregation and functional interactions. As
discussed in Chapter 2, CRABP 1 possesses a robust folding mechanism that protects it
from aggregation. However, the remaining question is how despite protective
mechanisms, CRABP 1 is drawn to aggregate. WT* CRABP 1 under native-like
conditions in vitro, aggregates to a minimal extent. However, this propensity is further
aggravated by addition of small amounts of denaturant or introduction of single residue
substitutions that do not affect the protein’s overall stability. In this chapter an
aggregation-prone intermediate populated under near native conditions was identified.
Using several biophysical tests, we show that the inherent “breathing” of CRABP 1
exposes the highly aggregation-prone segments identified in Chapter 2. This dynamic
motion is associated with the innate movement of the helical domain away from the βbarrel body and the loosening of interactions in the ligand portal region. However,
previous studies show that interaction with the ligand halts this motion and stabilizes the
complex (Krishnan, et al., 2000, Xiao & Kaltashov, 2005). Here we will demonstrate
inhibition of aggregation by retinoic acid suggests the role of ligand interactions in
offsetting aggregation. Our findings on the aggregation of CRABP 1 demonstrate the
complex intimate overlap between folding, functional roles and aggregation of proteins.

3.1.1. Native State Dynamics and Aggregation Propensity
In this section, we will recollect how the behavior of native proteins are currently
viewed and from here highlight circumstances that endanger native proteins towards
aggregation. By looking at crystal structures one might picture folded proteins as having
rigidly fixed conformations. But in reality, protein fluctuations around the native structure
may be attributed to its function to either form interactions with other proteins or binding
specific ligands. Descriptions of how proteins form specific interactions have developed
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through the years. The classical mechanism of a “lock and key” model initially proposed
by Emil Fischer where an enzyme interacts with its substrate via exact geometric
complementarity has evolved into a more mechanistically dynamic interaction referred to
as the “induced fit” model (Koshland, 1958, Csermely, et al., 2010). In the induced fit
model, binding events between a protein and a rigid ligand promotes conformational
changes (Koshland, 1958). However, more recently it has been proposed that the native
state is not only one distinct conformation but an ensemble of states for which protein
binding follows a “conformational selection” process. This paradigm suggests that
proteins fluctuate forming a conformational ensemble and a ligand selects one form
compatible to binding and shifts the equilibrium towards this state (Csermely, et al.,
2010). This is described as “conformational selection and population shift phenomena”.
In Chapter 1 native state ensembles have been described through multiple shallow wells
in the energy landscape. The heights of energy barriers associated with protein motions
can be described based on their timescales (Henzler-Wildman & Kern, 2007) (Figure
3.1). Fast protein dynamics involves local flexibility through bond vibrations, methyl
rotations, loop motions and side-chain rotamers, which are in femtoseconds to
nanoseconds timescales (Henzler-Wildman & Kern, 2007). Slow protein dynamics are in
the microseconds to millisecond timescales demonstrated by large domain movements
and collective motions (Henzler-Wildman & Kern, 2007). The rapid fluctuations have
very low energy barriers compared to slower motions (Henzler-Wildman & Kern, 2007).
Of the two types of dynamics, ensembles in slow timescales are more relevant to protein
functions.

Selection for functional conformations of proteins have already been described
experimentally (Csermely, et al., 2010). Nevertheless, although the initial steps for ligand
recognition of conformational selection and induced fit paradigms are different, the
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distinction is not very clear since several interactions appear to require both. The model
was then further refined into an “extended conformational selection” process (Wlodarski
& Zagrovic, 2009). This extension describes that the binding process not only changes
the energies of the interacting partners but also alters the shape of the entire energy
landscape (Csermely, et al., 2010). This was clearly illustrated in an NMR study on
structural ensembles of ubiquitin during binding revealing equal contributions from both
conformational selection and conformational rearrangements (Wlodarski & Zagrovic,
2009). The ability of proteins to form interactions by sampling several conformations
implies the possibility of visiting a high-energy poorly populated state prone to form
undesired self-interaction (Neudecker, et al., 2012). In the following section, we will show
a few examples of proteins that demonstrate the progressive view of an interconnection
between function and aggregation.
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Figure 3.1. One-dimensional cross-section through the high-dimensional energy
landscape of a protein showing the hierarchy of protein dynamics and the energy
±

barriers. ∆G corresponds to the free energy barrier between the populated states. Tiers
are divided according to the timescales of protein motions. Tier 0 represents slow
dynamics associated with large domain motions important for protein functions.
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3.1.2. Linkage between Functional Interactions and Aggregation
In Chapter 1 we have mentioned several proteins that aggregate under
physiological conditions suggesting a connection between functional dynamics and
aggregation. From the view of conformational selection, aggregation may be an outcome
of high energy less populated states of the native state ensemble (Csermely, et al., 2010,
Neudecker, et al., 2012). A systematic study conducted on protein-protein complexes
from structures deposited in the Protein Data Bank (PDB) showed evidence on shared
physicochemical properties between functional interfaces and aggregation-prone regions
(Pechmann, et al., 2009). In this study, the interface regions correlated with aggregation
hotspots projected on protein surfaces (surface aggregation propensity) of homodimers,
heterodimers and homotrimers (Pechmann, et al., 2009). In all cases, hydrophobic
interactions were the best indicator for functional and aberrant protein-protein
associations (Pechmann, et al., 2009). There have been a small number of studies
directly showing functional interfaces in proteins forming aggregates. We will briefly
discuss these few examples, which include the cases of ataxin-3, p53, β-lactoglobulin
and SUMO proteins.

3.1.2.1. Ataxin-3
Ataxin-3 (atx3) is a conserved and ubiquitously expressed enzyme whose
function is not yet clearly understood (Matos, et al., 2011). However, there have been
several evidence pointing to its important role in protein turnover by the UbiquitinProteasome Pathway because of its ability to recognize polyubiquitin chains and polyUbediting proteolytic activity. Atx3 interacts with a number of proteins involved in protein
homeostasis maintenance, transcription regulation, cytoskeleton organization and
myogenesis. The structure of ataxin-3 is composed of a structured globular N-terminal
domain referred to as Josephin domain (JD), which is responsible for the protease
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activity followed by a flexible C-terminal tail consisting of ubiquitin binding motifs and a
polyglutamine (polyQ) region. Increased length of the polyQ expansion has been
associated with neurodegeneration called Machado-Joseph disease (MJD), the most
common form of spinocerebellar ataxia. Atx3 presents as inclusions in neurons and
axons in brains of patients suffering from MJD. In addition, quality control proteins
including ubiquitin and molecular chaperones co-aggregate with atx3 in diseased brains.
It has been shown that in the absence of the polyQ tail, atx3 aggregates under native
conditions (Gales, et al., 2005). It is shown that the folded Josephin domain modulates
the stability and regulates self-association (Masino, et al., 2004). Under these native
conditions, Josephin domain nucleates atx3 fibrillation suggesting it role in the early
stages of aggregation (Masino, et al., 2004, Gales, et al., 2005). A detailed study to
identify aggregation-prone regions of Josephin domain uncovered two solvent exposed
patches (Masino, et al., 2011). These solvent exposed interfaces have been identified to
be important in ubiquitin binding (Masino, Nicastro et al. 2011). To further demonstrate
competition between self-association and functional interactions, they showed that
addition of ubiquitin slowed down aggregation and changed the morphology of
aggregates (Masino, Nicastro et al. 2011).

3.1.2.2. p53 protein
p53 is a tumor suppressor protein that is central to an extremely complicated
cellular signaling network. p53 mediates a wide range of responses by recognizing
signals for oncogene activation, DNA damage and oxidative stress and to initiate repair
mechanisms, cell cycle arrest or apoptosis (Aylon & Oren, 2007). Approximately half of
known cancers have mutations in the p53 gene. Majority of these cancers have
impairment in the positive and negative transcriptional regulation of function of p53. p53
is active as a tetramer. The N-terminus consists of disordered transactivation domain
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(TAD) and a proline-rich region (Joerger & Fersht, 2008). The central region consists of
a folded DNA-binding core domain linked to a tetramerization domain (Joerger & Fersht,
2008). At the C-terminus of p53 is a disordered basic regulatory domain which binds
DNA non-specifically (Joerger & Fersht, 2008). Post-transcriptional modification of the
p53 by phosphorylation, acetylation, methylation and modifications with ubiquitin-like
proteins affects its function and stability (Vousden & Lane, 2007). Aside from the effects
of mutations in p53 for its multiple functions, p53 is also shown to aggregate. Large
aggregates of wild-type p53 protein have been observed in the cytoplasm and nucleus of
neuroblastomas, carcinomas and myelomas (Moll, et al., 1996, Ostermeyer, et al.,
1996). Succeeding experiments to reveal the nature of the aggregates revealed the
tendency of its functional domains to self-associate. The central DNA binding domain,
the tetramerization domain and the disordered TAD have all been found to be involved in
the cores of aggregates (Ishimaru, et al., 2003, Higashimoto, et al., 2006, Rigacci, et al.,
2008). It has been reported that kinetic partitioning between folded and misfolded
proteins lead to a decrease in DNA binding for p53. Consistent with a common DNA
binding interface and aggregation cores, interaction of p53 with a consensus DNA
sequence inhibits aggregation.

3.1.2.3. β-lactoglobulin
β-lactoglobulin is a non-obligate homodimeric, β-barrel protein consisting of eight
anti-parallel strands (A-H) with an extra stand, I, which is involved in dimerization and a
helix at the C-terminal end. At low pH, the dimer dissociates into folded monomers
(Uhrinova, et al., 2000, Hamada & Dobson, 2002). β-lactoglobulin is a member of the
lipocalin family and has a large structural plasticity (Gutierrez-Magdaleno, et al., 2013).
Its large hydrophobic cavity enables it to bind to diverse hydrophobic ligands (GutierrezMagdaleno, et al., 2013). Based on calorimetric studies, ligand binding promotes dimer
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dissociation (Gutierrez-Magdaleno, et al., 2013). The protein also contains two disulfide
bonds which links strands D and I and G and H. Under denaturing conditions, βlactoglobulin forms aggregates but only after prolonged incubation. However,
aggregation can be triggered by reduction of disulfide bonds. Under oxidizing
environments, strand I is stabilized by disulfide bonds and favors dimerization. However,
under reducing conditions, strand I frays away from the β-barrel and leading to
aggregation (Hamada, et al., 2009). β-lactoglobulin exhibits another case where
functional dimerization interfaces coincide with aggregation-prone regions. In addition,
the ability of ligand binding to compete with dimerization may also provide some hint on
the possible role of natural ligands in preventing aggregation.

3.1.2.4. SUMO Proteins
Small ubiquitin-related modifier (SUMO) proteins are highly conserved proteins
covalently bound to target proteins. Unlike ubiquitin, SUMO proteins do not target
proteins to degradation rather they modulate protein-protein interactions. SUMO posttranslationally attaches to proteins via a isopeptide bond and participate in transcriptional
regulation, nuclear transport, maintenance of genome integrity, and signal transduction
(Johnson, 2004). The downstream effect of sumoylation varies for every substrate.
SUMO can either promote complex formation of substrates but can also prevent
interactions such as blocking ubiquitination. Similar to ubiquitin, SUMO proteins have a
ββαββαβ fold. The two C-terminal Gly residues required for isopeptide bond formation is
conserved between ubiquitin and SUMO. SUMO-1 contains a long and flexible N
terminus, which projecting from the core of the protein not found in ubiquitin. There are
four isoforms of SUMO (1 to 4). SUMO 2 and 3 are highly homologous. SUMO
conjugation has been found to increase the solubility of proteins leading to exploration of
its possible role in regulating aggregation-prone proteins (Krumova, et al., 2011). In
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addition, SUMO proteins have been popularly used as solubility tags for recombinant
protein expression (Wang, et al., 2010, Peroutka Iii, et al., 2011). However, despite the
very high stability of SUMO proteins, slight perturbation of this protein leads to
aggregation. Detailed analysis of the aggregate structure of SUMO proteins reveals that
strand 2, is both involved in the binding interface with its substrates as well as in the
aggregation cores (Sabate, et al., 2012). Furthermore regions of SUMO that have high
aggregation propensities are also found in its functional interface (Sabate, et al., 2012).
Aggregation of SUMO provides direct evidence that the need for productive interactions
also provides risks towards dysfunctional interactions.

3.1.3. Protective Intrinsic Mechanisms From Aggregation
Although surfaces important for functional and dysfunctional interactions are the
same, proteins have been designed to prevent aggregation. Proteins have evolved
utilizing several intrinsic strategies to disfavor aggregation. Even during aggregation at
physiological conditions, the nature of energy barriers in the native state prevents the
population of aggregation-prone species (De Simone, et al., 2011). It is through these
barriers that are dictated by the amino acid sequence by which proteins remain soluble
in vitro or in cells (De Simone, et al., 2011). Here we will discuss concrete specific
interactions that create energy barriers to disfavor proteins form populating the
aggregation-prone state. These include presence of charged residues close to interfaces
and/or specific interactions involving disulfide linkages and salt bridges (Pechmann, et
al., 2009).

3.1.3.1. Charges and Aggregation Gatekeepers in Preventing Aggregation
Charged residues specify binding by either opposing or promoting interactions
thus playing a role in favoring functional protein-protein interactions over aggregation.
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(Vendruscolo & Dobson, 2007, Zhang, et al., 2011). Analysis of regions around proteinprotein interfaces revealed charged residues in proximity to these hydrophobic patches
(Pechmann, et al., 2009). Interface rims formed by the residues that bury <25 Å2 upon
binding are mostly composed of charged amino acids (Pechmann, et al., 2009). The
importance of charges on the solubility and binding of proteins has been emphasized in
a study of a charge-depleted S6 ribosomal protein (Kurnik, et al., 2012). The absence of
charges did not affect native interactions but triggered aggregation (Kurnik, et al., 2012).
The presence of charged amino acids commonly found close to aggregation-prone
regions also referred as aggregation “gatekeepers” inhibit aggregation (Rousseau, et al.,
2006). The existence of these structural gatekeeper residues flanking highly aggregating
segments suggests selective pressure against aggregation (Rousseau, et al., 2006,
Beerten, et al., 2012). Obstruction of interactions between aggregation-prone sequences
is achieved in several ways: 1) repulsive effect of the charged side chains (arginine,
lysine, aspartate, glutamate; 2) the entropic penalty on aggregate formation by large side
chains such as arginine and lysine and 3) incompatibility of residues with the βaggregate structure as in the case of proline residues (Reumers, et al., 2009). It has
been reported that mutation of gatekeeper residues result in a number of misfolding
diseases and other aggregation unrelated diseases such as van der Woude syndrome
(VWS), Fabry disease (FD), and limb-girdle muscular dystrophy (Reumers, et al., 2009).
In addition, aggregation-prone segments of critical proteins are the most gate-kept
(Reumers, et al., 2009). Intrinsically disordered proteins (IDPs) have also been shown to
flank aggregation-prone sequences (Abeln & Frenkel, 2008). IDPs are natively unfolded
proteins consisting of only few hydrophobic residues, more hydrophilic and charged
amino acids and plenty of repeats in their sequence (Rezaei-Ghaleh, et al., 2012). IDPs
have been proposed obstruct or sterically hinder interactions between aggregation-prone
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regions (Abeln & Frenkel, 2008). In addition to their safeguarding properties electrostatic
patches also facilitate chaperone interactions for proper folding (Rousseau, et al., 2006,
Lawrence, et al., 2007, Kurnik, et al., 2012).

3.1.3.2. Specific Interactions and Structural Adaptations to Prevent Aggregation
Largely hydrophobic regions in globular proteins are deeply buried in the core of
proteins to prevent aggregation. Specific interactions ensure that exposure of these
segments are avoided. Disulfide bonds and salt bridges stabilizing native interactions
are preferentially found in proximity to interfaces in protein-protein complexes
(Pechmann, Levy et al. 2009). In the case of β-lactoglobulin, reduction of disulfide bonds
lead to aggregation (Hamada, et al., 2009). In β-lactoglobulin, the strand involved in
dimerization is an edge strand. An edge strand is defined as a β-strand found at the end
of β-sheets or β-sandwiches, that are inherently aggregation-prone by readily forming
intermolecular H-bonding with a neighboring β-strand (Richardson & Richardson, 2002).
Edge strands are commonly exposed in proteins that natively form β hydrogen bonds to
form dimers or oligomers strands (Richardson & Richardson, 2002). In β-lactoglobulin,
the edge strand is structurally restrained by the presence of disulfide bonds (Hamada,
Tanaka et al. 2009). In a survey by Richardson and Richardson in 2002 of β-rich
proteins they identified several “negative designs” or structural adaptation strategies to
prevent aggregation. A number of specific interactions are employed by β-proteins to
screen unwanted edge strand interactions. β-barrels prevent edges through continuous
H-bonding around the barrel cylinder. Parallel β-helices protect β-sheet ends by
interaction with flexible loops. β-propeller, β-sandwich and single-sheet proteins combine
β-bulges, prolines, addition of charged side chains in the middle of the strand, shortened
edge strands and coverage by loop structures to protect edge strands (Richardson &
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Richardson, 2002). Free edges also contain bends and twists as protective mechanisms
strands (Richardson & Richardson, 2002).

3.1.3.3. Cellular Strategies to Favor Functional Interactions and Folding over
Aggregation
Although there have been several examples showing that protein aggregation
can be beneficial, it is generally a deleterious outcome in cells. However despite the
negative implications of aggregation, evolution has not successfully eliminated
aggregation-prone segments in proteins. This can be attributed to their important roles in
forming compact folded structures as well as in facilitating functional interactions. As
discussed in the previous section, proteins bear gatekeeping sequences and form
specific interactions to disfavor aggregation. However, these protection mechanisms
may be impeded in the cell. During synthesis of proteins, the nascent chains may have
not yet formed the necessary interactions to protect aggregation-prone sequences.
Moreover, in addition to the natural motions of native proteins that expose aggregation
hotspots the extremely crowded cellular environment makes it highly desirable to form
aggregates. Thus, evolution has accounted several ways to prevent these dreadful
outcomes. The most obvious cellular strategy is the existence of robust quality control
machineries that either assist proper folding or eliminate aberrant proteins. The complex
network of molecular chaperones consists of facilitators in de novo folding, refolding of
stress-denatured proteins, disaggregation, oligomeric assembly, protein trafficking and
assistance in proteolytic degradation (Hartl, et al., 2011). Interplay between molecular
chaperones and proteases are crucial in maintaining a functional proteome (Powers, et
al., 2012). However, since protein production can overwhelm the proteostasis network,
protein expression is also regulated. There is a very strong anti-correlation between in
vivo expression levels and rates of aggregation in proteins (Tartaglia, et al., 2007). In
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addition, since aggregation is concentration dependent, abundant proteins were found to
be highly soluble in cells (Castillo, et al., 2011). However, these proteins although highly
soluble can become susceptible to aggregation at high concentrations therefore these
are tightly regulated at the gene-expression level (Castillo, et al., 2011). Another
protective mechanism is cellular organization. It is tempting to think that the cellular
environment is a random mesh of non-specific interactions. In reality the cellular
environment is highly organized and designed for specific protein-protein interactions
(Pastore & Temussi, 2012). Furthermore, cellular machineries are spatially organized
and compartmentalization allows efficient folding in vivo (Gershenson & Gierasch, 2011).
In addition to this, proteins in cells are designed to self-organize into large multiprotein
complexes to prevent exposure of sticky surfaces (Gierasch & Gershenson, 2009).
There is also a high correlation between aggregation propensity and turnover rate of
proteins (De Baets, et al., 2011). Short-living proteins have been found to be more
aggregation-prone and have less chaperone interactions than proteins that live longer
(De Baets, et al., 2011).

3.1.4. Functional Dynamics of CRABP 1
The functional dynamics and interactions with the ligand of members of ILBP
family including CRABP 1, our model protein is well characterized. Here, I will review
what is known about the shared dynamic behavior of this family and CRABP 1 to clearly
demonstrate further on their structural susceptibility of towards aggregation.

3.1.4.1. Function of CRABP 1
The intracellular lipid binding protein family is involved in sequestering and
transport of fatty acids in the cytoplasm. These proteins have been shown to be
important cellular processes such as signal transduction, gene expression, growth and
76

differentiation (Zimmerman & Veerkamp, 2002). Cellular retinoic acid binding proteins in
particular have two isoforms, CRABP 1 and CRABP 2. CRABPs bind to all-trans retinoic
acids, to regulate gene transcription, cell proliferation and cell differentiation. CRABP 1
and CRABP 2 are highly homologous with 74% sequence identity and are extremely
conserved among species (Noy, 2000, Marcelino, et al., 2006). Despite the high
similarity CRABPs have different patterns of expression across cell types and at various
stages of development suggesting functional diversity (Noy, 2000). Both isoforms are
found in the cytoplasm while CRABP 2 is also localized in the nucleus. CRABP 1 and
CRABP 2 similarly bind retinoic acid but have distinct modes of transport (Noy, 2000,
Stachurska, et al., 2011). CRABP 1 is ubiquitous and is involved in enhancing retinoic
acid catabolism and buffering retinoic acid concentrations in cells (Stachurska, et al.,
2011). CRABP 1 modulates catalysis of retinoic acid metabolism by associating with
cytochromes P450 and discriminates trans-retinoic acid from cis-retinoic acid (Fiorella &
Napoli, 1991, Noy, 2000). However the exact mechanism of how CRABP 1 regulates
retinoic acid in cells still remains unclear. On the other hand, CRABP 2 activates nuclear
retinoic acid receptors (RAR) and regulates retinoic-acid-dependent genes (Stachurska,
et al., 2011). The affinity of CRABP 1 (Kd<0.4nM) for retinoic acid is higher compared to
CRABP 2 (Kd=2nM) (Norris, et al., 1994).

3.1.4.2. Dynamic Properties of CRABP 1 and Implications for Ligand Binding
Attributing to similar functions to transport large hydrophobic ligands ILBPs have
strong structural homology across species, cell types and ligands for this protein family
(Marcelino, Smock et al. 2006). The overall structure of ILBPs consists of an internal
cavity filled with ordered water molecules and a helix-turn-helix cap. A small opening
enclosed between the helical domain and turns 2 and 4 acts as a portal region of the
protein. Based on several crystallographic studies on ILBPs, ligands are bound within
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the barrel in a central internal water-filled cavity (Jamison, et al., 1994, Donovan, et al.,
1995, Jamison, et al., 1998, Zhu, et al., 1999, Krishnan, et al., 2000). The side chains of
buried hydrophobic amino acids govern the specificity and volume of the internal cavity
(Noy, 2000). In addition, water molecules in the cavity contribute to the protein’s stability
and proposed to assist in the displacement of ligands. The volume of cavities varies for
members of the family and correlates with the size of its ligand. Common ligand-binding
residues located at the helical motif, strands 2, 3, 4, 8, 9, 10 and turn 2 have been
identified in most ILBPs (Marcelino, et al., 2006). However the nature of the cavity in this
family is not well conserved. It is proposed that ILBPs require favorable hydrophobic
interactions to encapsulate the ligand but maintain large solvent-filled cavities to
accommodate diverse lipids (Massolini & Calleri, 2003, Marcelino, et al., 2006).

In particular the crystal structure of holo-CRABP 1 shows retinoic acid buried in
the binding cavity where the carboxy group interacts with two arginine residues and one
tyrosine residue at the end pocket. The β-ionone ring is twisted into a cis-like
configuration relative to the isoprene tail, and fits snugly at the portal region leaving only
one end accessible to the solvent (Kleywegt, et al., 1994, Thompson, et al., 1995). Thus
in this closed ligand-bound conformation access to the entrance of the ligand-binding
pocket of CRABP 1 is restricted, implying that significant structural changes are required
to release the ligand.

It is currently recognized that the conformational flexibility of CRABP 1 like other
members of the iLBP family is associated with its function to recognize and bind ligand.
The highly flexible and conserved helical subdomain identifies the correct ligand to bind.
It is proposed that electrostatic interactions at the edge of the portal attract ligand into
the interior of the cavity (Zimmerman & Veerkamp, 2002). A conserved gap is found
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between strands 4 and 5 with no inter-strand hydrogen bonds is instead occupied by
ordered water molecules.

There have been three proposed mechanisms of ligand entry in iLBPs. One
mechanism based on well-ordered and superimposable crystal structures of apo and
holo forms of rat intestinal fatty acid binding protein, states that entry of the ligand
through the small portal requires minimal changes in the backbone conformation
(Sacchettini, et al., 1992, Sacchettini & Gordon, 1993). It is hypothesized that entry of
the ligand into the portal pushes the water molecules through the conserved gap similar
to a “water pump” (Sacchettini, et al., 1992). However this was challenged by another
hypothesis where ligand binding was shown to promote significant backbone
conformational changes. Limited proteolysis on cellular retinol binding proteins (CRBP I
and CRBP II), CRABP 1 and heart FABP revealed differential proteolytic patterns
between the apo and holo forms of the proteins (Jamison, et al., 1994). Increased
susceptibility for digestion at the entry site of the apo form compared to the holo-form
suggests an open conformation in the absence of a ligand. This was also supported by
prominent differences in crystal structures of apo and holo forms of CRABP 1, showing a
ligand accessible form where turn II moves away from the β-barrel (Thompson, et al.,
1995). Upon ligand binding the protein is locked in a closed state (Thompson, et al.,
1995). In an NMR study the apo-form of CRABP 1 shows a more flexible C-terminus of
helix II permitting increased access to the cavity (Rizo, et al., 1994).

However, a refined and detailed mechanism based on NMR studies suggests an
extended conformational selection process by which ligand binds. Hodsdon and Cistola
in 1997 proposed that existing locally disordered and ordered states of the protein in
equilibrium in the apo state. Ligand binding consequently stabilizes cooperative
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interactions shifting the equilibrium towards the ordered conformation. This is also
referred to as the ‘dynamic portal hypothesis”. Hudsdon and Cistola described four key
features in the dynamic portal hypothesis. First, there are several locally disordered
regions in the unbound. These include the C-terminal helix II, the linker between helix II
and strand 2, turn II and turn IV. These regions are flexible and capable of large
backbone structural fluctuations opening the portal region. This conformational change is
a transition between order and disorder where helix II and turn II interactions dissociate
and the C-terminal helix II is unraveled. Second, binding of ligand shifts the equilibrium
into an ordered or closed state by stabilizing interactions in the C-termini of helices I and
II. The C-terminus of helix I is stabilized by a Schellman motif interaction. On the other
hand the C-terminus of helix II is held by ligand-induced interactions with turn II. Third,
hydrogen bond interactions between a polar residue in turn II and helix II regulate the
order-disorder transition, hence the entry and exit of the ligand as well. Lastly, ligands
are released from the cavity by destabilization of turn II-helix II interactions to shift the
equilibrium into the disordered state. This may be driven by collision of the holo-protein
with target intracellular organelles. One proposal regarding the delivery of ligands into
the membranes requires the portal region (helix II, turns II and IV) to dock into the
membrane while the other side (strands 2, 3, 6, 7, turn 7 and the N-terminus) is exposed
to the solvent (Mihajlovic & Lazaridis, 2007).

Conformational exchanges along the portal regions have been consistently
observed in several ILBPs (Zhu, et al., 1999, Krishnan, et al., 2000, Lu, et al., 2000, Xiao
& Kaltashov, 2005, Li & Frieden, 2006). In addition, molecular dynamics simulations
have revealed backbone flexibility in apo-forms of iLBPs (Woolf, et al., 2000, Bakowies &
Van Gunsteren, 2002, Levin, et al., 2010). Examination of motions and flexibility of
CRABP 1 showed consistent dynamic behavior at the portal region. Using rapid
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hydrogen-amide exchange NMR, motions of the apo and holo-forms of CRABP 1 were
examined (Krishnan, et al., 2000). Significant distinct millisecond timescale motions were
observed in the portal region of the apo-form of the protein consisting of the C-terminus
of helix II, helix II-strand 2 linker, turn 2 and turn 4 supporting the dynamic portal
hypothesis (Krishnan, et al., 2000). In a separate experiment using slow hydrogen
exchange mass spectrometry, transient structural disorder was observed in the same
regions of the unbound protein (Xiao & Kaltashov, 2005). When bound to retinoic acid,
these fast motions are impeded and the flexibility in the portal is significantly reduced
(Krishnan, et al., 2000, Xiao & Kaltashov, 2005). Retinoic acid also increased the
conformational stability of strand 10, which contains residues that form two salt bridges
with the carboxylate group of retinoic acid (Xiao & Kaltashov, 2005). Studies on CRABP
1, consistent with other ILBPs reveal the crucial role of localized dynamics along the
portal region in dictating ligand recognition and subsequent conformational stabilization.
In the next section we will show our results suggesting that despite several protective
mechanisms against aggregation, this dynamic behavior predisposes the protein to
aggregation.

3.2. Results
3.2.1. Aggregation Propensities and Themodynamic Stabilities are Coarsely
Correlated
In Chapter 2 we have identified aggregation cores in CRABP 1, which were
consistent under extremely different conditions and across mutants with different
propensities to aggregate. Our first instinct was to check whether global unfolding
exposes these segments of the protein favoring intermolecular contacts. To do this we
looked for correlation between thermodynamic stabilities and aggregation propensities.
In order to do this, we checked the solubilities of several CRABP 1 mutants by cell
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fractionation after overexpression in E. coli with ∆∆GU-N (energetic effect of mutations on
the free energy of the unfolded state (U) with respect to the native state (N) = ∆GU-NWT ∆GU-NMutant) values determined by previous members of the lab. While we have found
high correlation between aggregation propensities and thermodynamic stabilities based
on ∆∆GU-N for weakly and highly aggregation-prone variants, the range of stabilities of
moderately aggregating CRABP 1 variants were relatively broad (Table 1). This coarse
correlation between stability and aggregation propensities may suggest other
mechanisms other than global destabilization are involved. The comparable tendencies
of moderately aggregating mutants to both fold and misfold may suggest that
aggregation may emerge from a folded intermediate. These mutants are able to acquire
the native fold based on their high solubility early on during overexpression or during
expression at low temperatures. The natively folded mutants have been confirmed by
CD spectroscopy (Appendix H) and intrinsic tryptophan fluorescence spectroscopy
experiments (Appendix I).

3.2.2. Aggregation of CRABP 1 Proceeds Under Native Conditions
To test whether a folded intermediate precedes aggregation, we examined
whether aggregation of CRABP 1 takes place under native conditions. We tested in vitro
conditions that lead to aggregation of WT* CRABP 1. Addition of low urea
concentrations or adjusting the pH below 8.0 leads increases aggregation propensity.
Here we followed aggregation of CRABP 1 at pH 7.0 in the presence of low
concentrations of urea ranging from 0.5 to 3M (Figure 3.2). We have found an increasing
trend towards aggregation up to 2.5M urea. Above 3M, aggregation is no longer
observed. At this range of urea concentrations, CRABP 1 has not yet globally unfolded
as shown in the equilibrium unfolding of CRABP 1 monitored by intrinsic tryptophan
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fluorescence (Figure 3.2). At higher urea concentrations (>4M), CRABP 1 begins to
unfold globally, however we do not observe aggregation under these conditions. To
observe the effects of low urea concentrations on the aggregation kinetics of CRABP 1,
we monitored the linear light scattering of CRABP 1 with and without urea. We observe a
faster rate of aggregation in the protein solution containing 1 M urea (Figure 3.3). Our
results reveal the existence of a near-native intermediate populated at low urea
concentrations. In addition, we show that this intermediate cannot be sensitively
detected using intrinsic tryptophan fluorescence, which has been used to monitor
unfolding of CRABP 1 (Clark, et al., 1996, Clark, et al., 1998). We also examined the pH
dependence of CRABP 1 aggregation by monitoring the aggregation propensity of
CRABP 1 at pH conditions below 8.0. We have found an increasing propensity to
aggregate as pH is adjusted away from pH 8.0 (Figure 3.4)
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Figure 3.2. Urea-dependent aggregation and unfolding of CRABP 1.
In red, aggregation of CRABP 1 plotted with urea concentration. Aggregation was
performed by incubation of 200 uM WT* CRABP 1 in buffer (10 mM phosphate buffer, 5
mM DTT pH 7.0) with increasing urea concentrations for 12 hours at 37oC. Aggregated
proteins were quantified by measuring amount of remaining soluble protein after
aggregation.
In blue, is a representative plot of fraction unfolded protein (blue) as a function of urea
concentration. Fraction unfolded is measured at different urea concentrations using
intrinsic tryptophan fluorescence spectroscopy.
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Figure 3.3. Aggregation kinetics of CRABP 1 with and without urea
Aggregation of 300 µM WT* CRABP 1 in 10 mM phosphate buffer, 5 mM DTT pH 7.0
monitored by linear light scattering without (filled circles) and with (open circles) 1.5M
urea.
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Figure 3.4. pH-dependence of CRABP 1 aggregation.
Aggregation reactions were performed on 200 µM WT* CRABP 1 at 37oC at different pH
conditions.
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3.2.3. Near-Native Dynamic Intermediate of CRABP 1 Leads to Aggregation
To provide detailed structural information regarding the species responsible for
the low urea dependent aggregation, we conducted equilibrium unfolding experiments
and monitored chemical shift perturbations by NMR. By monitoring changes in chemical
shifts of amino acid residues upon urea titration, we are able to identify regions of the
proteins that are perturbed by urea. Consistent with our model we observed the
population of a native-like intermediate prior to unfolding of CRABP 1. We describe our
findings on the urea unfolding of CRABP 1 as a two-step process. The first step takes
place at low urea concentrations manifesting a two-state transition, which is fast in the
NMR timescale (us-ms timescale) (Figure 3.5). A quick glance at the overall spectra
shows that only a few peaks are affected by urea. Most of the residual peaks at low urea
concentrations did not deviate from the chemical shifts corresponding to the native
protein (0M urea). We have looked closely at the few peaks perturbed by low urea and
found a two state equilibrium exists under these conditions (Figure 3.6). This suggests a
dynamic interconversion between states. This suggests that the intermediate being
populated as urea concentration is increased resembles that of the native state. The
interchange between the two species is fast as evidenced by single broadened peaks.
Broadening of peaks means that the rate of exchange between is faster compared to the
chemical shift differences of the two resonance lines. This suggests a dynamic
interconversion exists between the two structurally similar species. We will refer to this
intermediate as the N* state. The second step involves global unfolding depicted by the
slow transition from the N* state into the unfolded protein (Figure 3.7). In the second
step, as shown in concentrations above 3.5M, two species are in equilibrium, the N*
state and the unfolded state (U). This can be observed in the HSQC spectrum of CRABP
1 in 4M urea where peaks corresponding to both the N* state and U states are visible
(Figures 3.7 and 3.8). At this urea concentration, the interconversion is said to be slow
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because the rates of exchange is smaller compared to the chemical shift differences
allowing the two resonance lines to be resolved.
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Figure 3.5. Overlay of 1H-15N HSQC spectra of CRABP 1 at different urea
concentrations showing the first (fast) step of urea equilibrium unfolding of
CRABP 1 (N! N*). Colors represent increasing urea concentrations from 0.5 M (yellow)
to 3.5 M (red). Unperturbed chemical shifts in the absence of urea, in black.
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Figure 3.6. 1H and 15N chemical shifts monitored as a function of urea
concentration for highly perturbed residues. CRABP 1 undergoes a transition from
N-state ! N*-state. at low urea concentrations
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Figure 3.7. Overlay of 1H-15N HSQC spectra of CRABP 1 at different urea
concentrations showing the second (slow) step of urea equilibrium unfolding of
CRABP 1 (N*! U). Colors represent urea concentrations 4M (blue) and 8M (red).
Unperturbed chemical shifts in the absence of urea, in black. In 4M urea, CRABP 1
exists in equilibrium as N, N* and U states.
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Figure 3.8. Selected regions of the overlapped 1H-15N HSQC spectra of CRABP 1 at
different urea concentrations showing the second (slow) step of urea equilibrium
unfolding of CRABP 1 (N*! U). Colors represent urea concentrations 4M (blue) and
8M (red). Unperturbed chemical shifts in the absence of urea, in black. Shown is residue
T75 where peaks appear in both the N* and U in states in 4M urea.
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To gain insight on this intermediate, we identified residues perturbed by urea and
projected them on to the structure of CRABP 1 (Figure 3.9). These residues include the
helical subdomain and several loop regions of the protein. Inspection of the highly
perturbed regions supports a dynamic movement of the helical region away from the βbarrel

structure.

Furthermore,

the

intermediate

is

characterized

by

moderate

perturbations in the beta strands suggesting an increased breathing in the beta barrel
subdomain with large motions along the loop regions.

We further examined this intermediate using native state hydrogen deuterium
exchange NMR. We performed hydrogen exchange on WT* CRABP 1 with and without
urea. Our experiments showed fast amide backbone proton exchange along the helical
subdomain, loops and turns of the protein (Figure 3.10). Addition of urea increased the
rates of exchange in the same regions of the protein (Figure 3.11A). Figure 3.11B shows
that urea only increased the rate of exchange as seen with the faster decrease in
intensity with urea for representative residues. Our observations on our hydrogen
exchange experiments cannot completely dissociate the possibility of unfolding.
However, we found very good correlation between the perturbed residues from our
chemical shift perturbation analysis and highly solvent accessible residues identified by
hydrogen exchange (Figure 3.12). In addition residues that have been identified using
both methods corresponded to dynamic regions in the portal of the protein reported
previously by fast hydrogen exchange NMR and slow hydrogen exchange MS
experiments on CRABP 1 (Krishnan, et al., 2000, Xiao & Kaltashov, 2005). Previous
rapid water-amide hydrogen exchange and our chemical shift perturbation analysis
showed consistent dynamic regions in apo-CRABP 1 (Appendix J). In addition to this, we
performed partial trypsin digestion of CRABP 1. We observed faster digestion of trypsin
with upon addition of urea (Appendix K and Appendix L). The two major masses that
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were generated from the mass spectra of all the tryptic peptide fragments have values of
11079.2 and 7127.5 (average masses). The analyses yielded other peptide masses that
are within the range of 10000-12000 for the larger fragments and 6000-8000 for the
smaller ones. The predominant fragment (MW=6393) corresponded to residues along
turn 4 (regions around R78, K79 and R81), which is part of the ligand portal. Increased
protease accessibility was also previously reported corresponding to increased
dynamics of the apo CRABP 1 (Jamison, et al., 1994). We are currently working on
experiments to identify other regions of the CRABP 1 that become more accessible to
proteases in the N* state. Our data suggests that enhancement of the movement of the
helical subdomain and increased breathing of the beta barrel region of CRABP 1 which
is an intrinsic behavior of the protein to accommodate its ligand also relaxes stable
interactions between the beta stands leading to exposure of the aggregation-prone
sequences.
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Figure 3.9. Residues perturbed by urea mapped on to the structure of CRABP 1.
Residues in CRABP 1 that showed high (green spheres) and moderate (green highlight)
chemical shift perturbation upon addition of low amounts of urea.
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Figure 3.10. Backbone solvent accessibility of WT* CRABP 1. Fast exchanging
(yellow) and slow exchanging residues (blue) monitored by H/D exchange were
consistent in with and without urea. Residues not analyzed are in black.
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Figure 3.11. Exchange rates of CRABP 1 residues with and without urea
A) Rates of backbone amide proton exchange of amino acid residues of WT* CRABP 1
with (red dotted lines) and without (blue dotted lines) of urea. β-strands (highlighted in
yellow) and α helices (highlighted in teal) in the sequence are shown. Aggregation core
sequences are highlighted in black.
B) Ratio of peak intensities with time of representative residues in WT* CRABP 1 with
(red) and without (blue) urea. I0: peak intensity before exchange; Iex: peak intensity after
exchange.
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A)

B)
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Figure 3.12. Highly dynamic near native intermediate exposes aggregation-prone
sequences.
Regions of CRABP 1 with high chemical shift perturbation and fast exchanging residues
monitored by HX-NMR (purple spheres), high chemical shift perturbation only (blue
spheres), fast exchanging residues only monitored H/D exchange NMR (red spheres)
and aggregation cores (orange highlight) mapped on to the CRABP 1 structure.
Residues sensitive to urea cluster along regions of the protein that allows exposure of
aggregation cores.
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3.2.4. Effect of single residue substitutions on CRABP 1 aggregation
To examine the effects of mutations that leads to aggregation, we monitored
chemical shift perturbations brought about by single residue substitutions around the
aggregation cores F50M, F65M, G68A, F71M, G78A (core residues 51-65) and L118V
(C-terminal core) (Figure 3.13). We have only observed local perturbations near the
mutation sites in these variants suggesting that global unfolding of the protein is not
required in these mutants. Our data suggests that local perturbations around the core
sequences in the folded structure may be increasing the dynamics of the protein and
enhances the exposure of these aggregation-prone segments. We are currently
validating our observations by monitoring the dynamics of aggregation-prone mutants
using hydrogen exchange.

110

Figure 3.13. Locations of single residue substitutions that favor aggregation
mapped with aggregation cores. Aggregation-prone mutants CRABP 1 only lead to
local perturbations in the structure. Amino acid residues that have been mutated and
shown increased propensities to aggregate (teal spheres) are clustered close to the
aggregation cores. Chemical shift analysis of these mutant proteins showed only local
perturbations near the mutation sites.
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3.2.5. Retinoic acid binding decreases aggregation of WT* CRABP 1
It has been previously reported that binding of retinoic acid reduces the dynamics
of CRABP 1 (Krishnan, et al., 2000, Xiao & Kaltashov, 2005). To test whether
stabilization of CRABP 1 by retinoic acid can decrease the aggregation of CRABP 1 we
performed an in vitro aggregation assay and monitored formation of aggregates with and
without retinoic acid. Since aggregation is a stochastic process, we performed multiple
trials to test the effect of retinoic acid on the aggregation propensity of CRABP 1. We
performed our assay under conditions that favor aggregation of CRABP 1 - high
concentrations (200 uM and above) in the presence of 1.5 M urea at pH 7.0 (Figure
3.14A). We found that the propensity to aggregate was greatly reduced by retinoic acid
(Figure 3.14). Out of 69 independent aggregation reactions, only 15 reactions showed at
least 20% of monomers forming aggregates in the presence of retinoic acid (Figure
3.14B) in contrast to 54 out of 77 independent aggregation reactions with at least 20%
monomers forming aggregates without retinoic acid (Figure 3.14A). Our findings support
the model that ligand binding prevents CRABP 1 from accessing this open dynamic state
by locking this helical domain close to the barrel inhibiting exposure of aggregation cores
preventing aggregation (Figure 3.15).
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Figure 3.14. Inhibition of CRABP 1 aggregation by retinoic acid. 54 out of 77
independent aggregation reactions showed at least 20% of CRABP 1 monomers forming
aggregates (A) while in the presence of retinoic acid, 15 out of 69 independent
aggregation reactions showed at least 20% of CRABP 1 monomers forming aggregates
(B). Aggregation reactions were performed by incubating 250-300 µM of soluble CRABP
1 in phosphate buffer pH 7.0 containing 1.5M urea at 37oC for 2 hours. Amount of
aggregated proteins were determined by measuring the amount of remaining soluble
monomers after incubation.
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B)
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Figure 3.15. Conserved sequences in CRABP 1 important for ligand binding and
aggregation. Conserved ligand binding residues in the iLBP family mapped on to
CRABP 1 (in red) are critical in not only in ligand interactions but in stabilization of
aggregation cores in the complex.
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3.3. Discussion
Despite several decades of trying to understand protein aggregation, there have
only been a handful of globular proteins with a well-explored aggregation energy
landscapes. The idea that native proteins are prone to aggregate has been progressively
explored recently. However, there is lack of a complete picture describing aggregation
risks and protective mechanisms from the early steps of folding to the fully functional
protein. For a long time we have been interested in questions on β-rich proteins: What
signals in the protein sequence favor folding over aggregation of these highly
aggregation-prone motifs? How do these proteins perform their functions despite the risk
of aggregation? We have used knowledge gained over the years on a β-rich protein
CRABP 1 to address these questions and provide clear connections between folding,
function and aggregation. In Chapter 2, we demonstrated how a protein’s sequence can
dictate both folding and aggregation. We have learned that folding assures early
protection of hydrophobic sequences to avoid aggregation. However, the question
remains why in spite of this folding driven protection of aggregation-prone segments
CRABP 1 is susceptible to aggregation under native conditions? We therefore
hypothesize that similar to other globular proteins, local fluctuations in CRABP 1 may be
leading to undesirable interactions. In order to provide connections between aggregation
and motions of the native protein, we identified conditions that favor aggregation and
examined the species populated. From here, we learned that indeed the protein’s
dynamic behavior directs exposure of these aggregation-prone segments.

We have found that addition of small amounts of denaturants increases the
aggregation propensity of CRABP 1. We were able to establish a strong correlation
between urea concentration and aggregation at concentrations prior to global unfolding
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of CRABP 1. Over the years, we have used intrinsic tryptophan fluorescence and
circular dichroism to monitor global unfolding. However, these methods have not been
sensitive in detecting species that become populated at low urea concentrations. Our
inability to detect these species using fluorescence methods and CD provided us more
hints that species leading to aggregation may not be largely destabilized. We therefore
used NMR and chemical shift perturbation analysis to sensitively monitor populations. In
addition, HX-NMR and partial proteolysis to monitor solvent and protease accessibility
were used to support our findings from the chemical shift perturbation analysis. Our data
from all three methods illustrate a dynamic breathing of CRABP 1 under native
conditions. Our NMR data on aggregation-prone variants with substitutions around the
aggregation cores displaying only local perturbations. In addition, we also found that
aggregation is sensitive to pH. NMR analysis of CRABP 1 in at pH’s from 7 to 8 showed
perturbation in two histidine residues, His40 and His94. His40 is slightly conserved and
interacts with Lys8 and Ser 55 (residue in strand 3). Protonation of His40 may break
interactions with strand 3 (part of aggregation core 1) thus exposing this core to
aggregation. The pH dependence of CRABP 1 aggregation has to be explored more in
detail especially at lower pH’s when acidic residues functioning as gatekeepers may be
perturbed. All together our observations supporting aggregation from mutations that only
locally perturb CRABP 1 further support an aggregation-prone intermediate with a
native-like structure.

The conformation we have identified been previously described as a natural
tendency of the molecule in the absence of retinoic acid. Fluctuations that occur along
the portal region of CRABP 1 bare the entry site for ligand to access and bind inside the
cavity. Although this dynamic portal model favoring ligand binding has already been out
for quite sometime, our data extends brand new insights regarding its role in preceding
119

aggregation. In this dynamic open state, the helical domain dissociates from the β-barrel
body and breaks interactions with loop II, thus exposing the highly fluctuating
aggregation-prone strands 3 and 4. In addition, this movement partly unmasks strand
10, transforming it into an edge strand exposing it to unfavorable intermolecular
interactions.

In previous reports, it has been emphasized that binding to retinoic halts CRABP
1 dynamics and stabilizes the protein (Krishnan, Sukumar et al. 2000(Xiao & Kaltashov,
2005). To support further our claim that similar motions predispose the protein to
aggregation, we tested whether a stabilized, rigid ligand-bound CRABP 1 is less prone
to aggregate. Consistent with our hypothesis, we show that retinoic acid is capable of
inhibiting aggregation. Protective strategies using functional interactions have already
been observed in proteins as discussed in the previous sections. CRABP 1 aggregation
presents an excellent case where a hydrophobic ligand protects the same hydrophobic
regions that drive aggregation. A similar competition between intermolecular interactions
and ligand binding has also been observed in another lipid binding protein βlactoglobulin. This protein has a similar cavity that binds hydrophobic ligands. As
discussed earlier, binding of ligand dissociates the dimer, which is stabilized by the
same regions in aggregates (Gutierrez-Magdaleno, Bello et al. 2013; (Hamada, et al.,
2009). The case of acylphosphatase also shows also a similar behavior. NMR
experiments combined with molecular dynamic simulations show that phosphate ions
acts as an inhibitor for protein aggregation of acylphosphatase (De Simone, et al., 2011).
It has been demonstrated that the binding interaction perturbs the energy landscape and
the dynamics of the protein to prevent aggregation even under conditions where it is
otherwise favored (De Simone, et al., 2011). This observation is proposed to be a
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general behavior in protein-ligand interactions to avoid aggregation (De Simone, et al.,
2011).

The functional relevance of the dynamic movement of CRABP 1 is shared with
other members of the ILBP family. Our findings on the aggregation mechanism of
CRABP 1 may have similar implications with other ILBPs. This family is not known for
any aggregation-related diseases. Hence we propose that this may be ascribed to the
ability of these proteins to shield aggregation via several mechanisms such as rapid
folding and protective ligand interactions. Ligand specificities of different ILBPs are
different, however there are conserved binding sites for these proteins. We find several
conserved binding sites at the helical sub-domain and aggregation-prone segments
(Figure 3.16). Our results imply that the interaction between the ligand with the helical
lid, loop 2, strands 3, 4, 9 and 10 have multiple functions: 1) to functionally lock the
ligand into the cavity with the helical lid; 2) to halt the motions along the portal region to
stabilize the complex; 3) to stabilize fluctuations in loop 2, strands 3 and 4 to prevent
exposure to aggregation; 4) to stabilize strand 10 (which forms a salt bridge with the
ligand) and subsequently strand 9 to avoid aggregation. Ironically, in all our folding
studies we have used the stabilized variant of CRABP 1, R131Q. As can be recalled,
Arg131 (which is part of the C-terminal aggregation-prone strand) forms a salt bridge
with the carboxyl group of retinoic acid to stabilize the complex. Mutation of Arg131 into
glutamine destabilizes the complex however increases the solubility and stability of
CRABP 1. This further suggests Arg131 interaction with retinoic acid offsets the lowered
solubility and stability of CRABP 1.

Hence we propose a model where under native conditions CRABP 1 is an
ensemble of low-energy states with slightly different energies separated by defined
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barriers. One of these states is a relatively higher energy open conformation, N* state
capable of both ligand binding and intermolecular association. In the presence of a
ligand, the equilibrium is shifted towards the lowest energy ligand-bound state. However,
in the absence of the ligand at high CRABP 1 concentrations, this high-energy state
becomes sufficiently populated permitting intermolecular associations shifting the
equilibrium towards the very low energy aggregated state (Figure 3.16).

In the absence of the ligand, how is the native protein protected from
aggregation? Analysis of the CRABP 1 sequence reveals presence of aggregation
gatekeepers (Clouser, 2011). These include D16, E17, K20, K30, D125 and D126. It is
predicted that helix II and partly helix I is highly aggregation-prone however we have not
found these in the aggregation cores. Thus, the presence of these charged residues
(D16, E17, K20 and K30) possibly safeguards this region against aggregation. We also
observed that residues D125 and D126 disrupt the aggregation core in the C-terminal
end of the protein resulting in a small gap between the aggregation cores. Thus, these
charged residues identified function as aggregation gatekeepers of CRABP 1. In addition
cellular conditions also protect CRABP 1 aggregation.

As we have discussed previously, aside from the general housekeeping
machineries that prevent aggregation in cells, protein concentrations of aggregationprone species are largely regulated. In human cells, CRABP 1 concentration is very low
(1-10 µM) and has relatively low saturation for retinoic acid (40nm) around 5% saturated
(Donovan, et al., 1995). Despite not having enough ligand in to bind retinoic acid, the
concentration of CRABP 1 is regulated to prevent aggregation. The cellular maintenance
of low CRABP 1 concentrations may be a mechanistic control to limit the amount of N*
state enough to trigger aggregation.
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Figure 3.16. Proposed aggregation free energy landscape of CRABP 1 under
native conditions. Native CRABP 1 samples a near-native conformation (N*), which is
linked to both ligand binding and aggregation. N* state can bind to retinoic acid to form a
stable complex or self-associate to form highly stable amorphous aggregates. This
illustrates the role of retinoic acid interaction in restructuring the energy landscape of
CRABP 1.
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In summary our work not only provides another case of a globular protein
aggregating from the native state but also describes natural features of the protein that
present risks to aggregation. As described earlier in this chapter, there have been only a
very few cases reported wherein oligomerization and binding interfaces also predispose
proteins to aggregation. The case of CRABP 1 presents a clear illustration of functional
interactions as protective mechanisms against aggregation. The overlap between
functional ligand binding interfaces and aggregation-prone regions highlights the
importance of natural ligands in designing small molecules against aggregation. In
addition, our contribution to the growing number of cases where globular proteins
aggregate from the native state supports the idea that not only folding dictates
aggregation propensity but the inherent motions of proteins as well. Although this implies
specific approaches in studying aggregation of globular proteins, shared characteristics
within protein families can also provide hints on their behaviors. Lastly, we have shown
that evolutionarily fine-tuned folding of a protein does not guarantee protection from
aggregation

therefore

this

emphasizes

the

critical

role

cellular

housekeeping

machineries to regulate protein concentrations in their soluble and functional states.

3.4. Experimental Procedures
In Vitro Aggregation Assays
WT* CRABP 1 proteins were generated using the same protocol described in
Chapter 2. Protein solution aliquots with known concentrations were lyophilized.
Lyophilized proteins were resuspended in buffer (10 mM phosphate buffer, 5 mM DTT
pH 7.0) containing different urea concentrations (0 to 3.0M) to a total reaction volume of
100uL. Each tube contains 200 µM of pure CRABP 1 protein. Aggregation reactions
were incubated and agitated at 1000rpm using a thermo shaker at 37oC for 12 hours.
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The amounts of soluble protein before and after aggregation were measured from
absorbance at 280nm (A280) of protein diluted in 8M urea. The same protocol was also
used to determine aggregates formed at different pH conditions. Briefly, aggregation of
CRABP 1 was monitored using phosphate buffers with pH’s from 6.0 to 8.0. Percent of
aggregated protein was determined by taking the ratio of the difference in A280 before
and after aggregation with respect to the initial concentration. A280(t=0) and A280(t=12)
are absorbance readings at 280nm before and after aggregation.

To monitor the effect of retinoic acid on WT* CRABP 1 aggregation, we
compared the amounts of aggregates formed after two hours of aggregation at 37oC
using the same method described above in the presence and absence of 100 µM
retinoic acid.
The effect of urea on the rate of aggregation was determined by measuring the light
scattering at 350nm every 30 seconds of 300 µM WT* CRABP 1 in buffer (10 mM
phosphate buffer pH 7.0 containing 5 mM DTT) with and without 1.5M urea using Varian
Cary 50 UV-Vis Spectrophotometer.

Equilibrium Unfolding Experiments
Equilibrium unfolding of WT* CRABP 1 in the presence of 0 to 8M urea were
monitored using solution NMR spectroscopy.

15

N-labeled WT* CRABP 1 was dissolved

in buffer (20 mM Tris buffer, 5 mM DTT, 5% (v/v) D2O pH=8.0) with or without urea.
HSQC spectra of WT* CRABP 1 for each urea concentration were recorded at 26 °C on
a 600-MHz Bruker Avance spectrometer using a TXI cryoprobe. Data were processed
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using NMRPipe (Delaglio, et al., 1995) and analyzed using Cara software (Keller, 2004).
15

N and proton chemical shifts for amino acid residues were assigned de novo using

triple resonance experiments HNCO, HNCACB, HNcoCACB.

Proteolysis of WT* CRABP 1
To determine the solvent accessibility of WT* CRABP 1 urea, we performed
limited trypsin digestion on WT* CRABP 1 with and without urea. WT* CRABP 1 was
dissolved in proteolysis buffer (10 mM Tris-HCl pH 7.6, 50 mM NaCl, 2mM CaCl2) and
treated with Trypsin Gold (Promega) to a trypsin:protein (w/w) concentration of 1:25 at
different time points at 30oC. Tryptic digests were ran in 15% Tricine SDS-PAGE for
analysis. MS experiments were done on a QStar XL Quadrupole TOF Mass
Spectrometer using TurboIon electrospray ionization. LC-MS/MS was done after
separation of the tryptic peptides on a C18 RP column using a gradient elution of 0-95%
acetonitrile/0.1% formic acid at a flow rate of 200 µL/min over 30 mins. MS peaks were
further fragmented for sequencing by collision-induced dissociation (CID). The mass
spectra were analyzed using the Bayesian Protein Reconstruct tool in AnalystQS
software while peptide sequences were determined by de novo sequencing.

Hydrogen Exchange of NMR
Hydrogen exchange was performed on WT* CRABP 1 in the presence and
absence of 1.5M urea. Lyophilized 15N-labeled WT* CRABP 1 was dissolved in buffer
(20 mM Tris-d11, 5 mM DTT pH 8.0) with or without 1.5M urea and lyophilized overnight.
Lyophilized protein was re-dissolved in D2O. H/D exchange was followed by
measurement of peak intensities in HSQC spectra acquired at different time times after
transfer of the protein in D2O.
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HSQCs were recorded at 26oC using a 700 MHz Varian NMR system equipped
with a cryogenically cooled triple-resonance probe. Total acquisition time for each 2D
HSQC spectrum was about 15 min. Data were processed using NMRPipe (Delaglio, et
al., 1995). Peak intensities for assigned residues as a function of time were analyzed
Peak intensities

for assigned residues as a function of time were analyzed using

homemade Mathematica scripts.
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CHAPTER 4
CONCLUSIONS

4.1. Summary
A polypeptide’s amino acid sequence has evolved to contain all necessary
information for proper folding and function. However, these interactions likewise govern
aggregation, which is associated in a number of catastrophic diseases. Thus, inherent
risks are also encoded in the protein sequence. In this thesis, we investigated the
existence of sequence determinants for folding and misfolding. To explore the molecular
basis of protein aggregation and to find connections with folding, we employed CRABP
1, a model β-rich protein with a complex topology and rugged energy landscape. Taking
advantage of several aggregation-prone mutants of CRABP 1, we have identified
aggregation-driving sequences in in vitro and in vivo aggregates. These short contiguous
amino acid segments encompass the ligand-binding portal and strands at the C-terminal
end of the protein consisting the aggregation interfaces. These aggregation cores
constitute aggregates derived in vitro and in vivo. Moreover, the experimentally
determined

aggregation

cores

validated

several

sequence-based

aggregation

predictions. However, we find that sequence-based predictions cannot fully recapitulate
the overall aggregation propensities of single residue mutants. Hence, considerations for
additional parameters are necessary to predict aggregation propensities such as protein
thermodynamic stabilities and dynamics. Our analysis of the aggregation core
sequences of CRABP 1 revealed clear connections between one of the cores, the Cterminal strand and folding. Folding studies indicate the critical role of N and C-terminal
docking during the early stages of barrel closure. Thus, we have learned that
fundamental steps in folding are directed by the protein’s natural tendency to avoid
aggregation.
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Our awareness on the role of folding as a protective mechanism from
aggregation led us to more questions on how proteins evade this. We further examined
the behavior of CRABP 1 under native conditions and resolved intermediates that
precede aggregation. Under non-denaturing conditions, we found that the natural
motions of CRABP 1 associated with its role to bind ligand triggers aggregation. The
dynamic behavior of CRABP 1 to open its ligand-binding portal to permit ligand access
exposes the aggregation cores. We further found the role of the ligand, retinoic acid in
stabilizing the complex, essential in preventing aggregation. We also established
connections with members of intracellular binding proteins that contain conserved
binding residues for ligands as these are located along the aggregation cores, further
justifying the importance of ligand interaction as a protection from aggregation. Finally,
we emphasized the relevance of low expression levels in vivo of CRABP 1 in facilitating
folding and function over aggregation.

4.2. Implications for Future Studies
This thesis has provided a holistic examination on three important intrinsic
behaviors of proteins: folding, functional dynamics and aggregation. It has provided the
much-needed linkage between the evolutionary requirement for proper folding for
function, as well as the inability to completely eliminate the risk of aggregation. The
foundations contributed on understanding the energy landscape of CRABP 1 opens
opportunities to explore other areas of the landscape including aggregation under nonnative conditions. In addition, our knowledge of aggregation-prone sequences in the
protein will assist further studies on conserved residues (aggregation gatekeepers) that
restrict aggregation. A more detailed analysis of the aggregation kinetics of CRABP 1
and its mutants may also provide additional insights in guiding predictions for
aggregation propensities. Likewise, CRABP 1 and its mutants may be used for
130

interrogating the roles of cellular quality control machineries (chaperones, degradation).
Currently, there is still a modest amount of information showing direct links between
protein sequence and interactions with the different quality control machineries. Interplay
and competition for hydrophobic sequences in folding, aggregation, function and that of
chaperones and degradation enzymes still remains to be understood in detail. CRABP 1
may be an excellent model for these studies to extract generic concepts in explaining
protein folding in the cell.

From an evolutionary point of view, it remains intriguing how proteins have not
been

efficiently

selected

against

sequences

that

trigger

aggregation.

It

is

comprehensible that aggregation-prone sequences and dynamic motions of proteins are
critical for function thus cannot be completely selected against, giving rise to intrinsic and
cellular protection mechanisms against aggregation. However, it remains confounding
why despite redundant protective mechanisms, there are still a growing number of
misfolding diseases. Hence, it brings also to the table the evolutionary constraint for
proteins to be multifunctional in the form of intrinsically disordered proteins. The
existence of disorder in proteins permits multiple functions but also consequently lead to
aggregation-related disease states. Therefore, understanding the balance between
evolutionary selection for optimal protein function and threat for misfolding and
aggregation remains as a huge area of study.
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APPENDIX A
PREDICTED AGGREGATION PROPENSITY OF CRABP 1
Aggregation propensities were predicted using Zyggregator (a), AGGRESCAN (b) and
TANGO (c).

A

B

C
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APPENDIX B
LOCATION OF MUTATIONS AFFECTING THE PREDICTED AGGREGATION
PROPENSITY OF CRABP 1
Isoleucine 52 is located in strand 2 (green sphere) and leucine 118 (blue sphere) is in
strand 9 of CRABP 1.
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APPENDIX C
PREDICTED AGGREGATION PROPENSITIES OF WT* AND I52A CRABP 1
Decreased aggregation propensities were observed around the mutation site predicted
by Zyggregator.
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APPENDIX D
PREDICTED AGGREGATION PROPENSITIES OF WT* AND L118V CRABP 1
Increased aggregation propensities were observed around the mutation site predicted by
Zyggregator.
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APPENDIX E
TRANSMISSION ELECTRON MICROSCOPY IMAGES OF CRABP 1 AGGREGATES
F71A in vitro and in vivo aggregates were resuspended in water. Ten microliters of the
aggregate resuspension was dropped on to carbon-coated copper discs. Concentrations
of samples were optimized so that only a very thin layer of aggregates forms at the
surface of the disc. Samples were dried out for a few minutes. Ten microliters of 1%
phosphotungstic acid was dropped on to the disc and allowed to dry for a few minutes.
After this, excess stain was washed off with distilled water. Discs were dries overnight
prior to visualization. In vivo aggregates (A) appeared as uniform globular structures in
contrast to the very amorphous in vitro aggregates (B).

A)

B)
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APPENDIX F
SDS-PAGE OF PURIFIED INCLUSION BODIES FROM SEVERAL AGGREGATIONPRONE MUTANTS
Several aggregation-prone mutants were purified using a mild non-ionic detergent.
Mutant CRABP 1 proteins predominantly consist the purified inclusion bodies.
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APPENDIX G
WESTERN BLOT OF CRABP 1 INCLUSION BODIES TO DETECT SMALL HEAT
SHOCK PROTEIN IBPA.
Inclusion bodies were probed against IbpA using rabbit anti-IbpA serum (from Dr. Tania
Baker, MIT) and anti- rabbit IgG AP conjugate as secondary antibody. Blots were
developed using Lumiphos reagent (Thermo Scientific).
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APPENDIX H
CD SPECTRA OF WT* AND L118V MUTANT CRABP 1
WT* (triangles) and L118V (squares) mutant CRABP I proteins (10 µM protein in 10 mM
Tris-HCl, 1mM TCEP pH 8.0) show similar CD spectra. CD signals were converted to
molar ellipticity (θ). CD spectra collected was an average of 10 scans. Mutant CRABP 1
contains the CD inflection at 228nm, which is characteristic of tertiary packing involving
aromatic clustering around Trp 87 and the aromatic-charge interaction between Arg 111
and Trp 109 in the native protein (Clark, et al., 1996)
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APPENDIX I
FLUORESCENCE SPECTRA OF WT* AND L118V MUTANT CRABP 1
Intrinsic tryptophan fluorescence spectroscopy was performed on 4uM WT* and L118V
mutant proteins in 10 mM Tris-HCl pH 8.0, 1mM DTT. Spectrum of L118V CRABP 1
(squares) was very similar to that of the WT* CRABP 1 spectrum (triangles). Maximum
fluorescence is observed at 330nm is observed in the native protein and is quenched
relative to the denatured state. Fluorescence quenching is attributed to the proximity of
Trp 109 to Cys95 in the native state (Clark, et al., 1996).
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APPENDIX J
DYNAMIC REGIONS OF APO-CRABP 1 FROM FAST HYDROGEN EXCHANGE
EXPERIMENTS
Shown in thick tubes are residues of CRABP 1 undergoing fast fluctuations in the
absence of CRABP 1. This figure is re-printed from (Krishnan, et al., 2000)
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APPENDIX K
PARTIAL PROTEOLYSIS OF CRABP 1
Partial trypsin digestion of CRABP 1 in 10 mM Tris-HCl pH 7.6, 50 mM NaCl, 2mM
CaCl2 showed appearance of two major fragments. Positions of fragments 1 (12KDa)
and 2 (6KDa) are indicated.
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APPENDIX L
PARTIAL PROTEOLYSIS OF CRABP 1 IN THE PRESENCE OF UREA
Partial trypsin digestion of CRABP 1 in 10 mM Tris-HCl pH 7.6, 50 mM NaCl, 2mM
CaCl2 ,1M urea showed appearance of two major fragments. The rate of proteolysis is
faster with 1M urea than without (Appendix K). Positions of fragments 1 (12KDa) and 2
(6KDa) are indicated.
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